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1.1 Adult neurogenesis 
 
Adult neurogenesis is a process of structural plasticity characterized by de novo 
generation and integration of new neurons into the existing circuitry in the adult 
central nervous system (CNS) (Ming and Song 2005; Christian et al. 2014). 
Basal level of neurogenesis occurs in two discrete regions: the subventricular 
zone (SVZ) in the lateral wall of the lateral ventricle and the subgranular zone 
(SGZ) of the dentate gyrus (DG) in the hippocampal region (Lois and Alvarez-
Buylla 1994; Kempermann and Gage 2000). These two areas, referred to as 
“canonical” sites of active adult neurogenesis, have been found in all 
mammalian species studied so far, including primates and humans (Eriksson et 
al. 1998; Gould et al. 1999; Knoth et al. 2010). The adult neurogenic process 
comprises a series of sequential developmental steps spanning from 
proliferation, survival, fate specification, neuronal migration, maturation and 
functional integration of neuronal progeny. The source of new neurons is the 
adult neural stem cell (NSC) and their progeny of neural progenitor cells 
(NPC), which were first isolated from the adult CNS of rodents by Reynolds 
and Weiss (1992) and Kilpatrick and Bartlett (1993). Their pioneering work on 
SVZ-derived NSC was pivotal, given that they reported methods for culturing 
and growing neural stem/progenitor cells (NSPC) in the neurosphere culture 
assay, where individual cells proliferate and generate clusters of cells in 
suspension. Additionally, these scientists obtained adhesive cultures of NSPC, 
grown as monolayers on coated substrates (such as laminin). In these 
proliferating conditions, basic fibroblast growth factor (bFGF) and epidermal 
growth factor (EGF) were defined as the primary mitogens used to propagate 
adult neural progenitors in vitro (Reynolds and Weiss 1992; Kilpatrick and 
Bartlett 1993). These studies established the basic protocols for keeping and 
maintaining NSPC self-renewal property among many passages, as well as their 
multipotentiality. Under these conditions the differentiation ability of NSPC is 
maintained over many passages and can be observed upon growth factor 
removal, when the molecular machinery drives the differentiation toward the 
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neural lineages, neurons, astrocytes and oligodendrocytes. Later on, similar 
protocols were also developed to expand and differentiate NSPC derived from 
the SGZ of the hippocampus (Gage et al. 1995). 
 
The adult rodent SVZ contains four distinct cell types defined by their 
morphological features, molecular markers and electrophysiological properties: 
(1) migrating neuroblasts, type A cells; two distinct populations of NSPC, type 
B (2) and type C (3) cells; and (4) ependymal ciliated (type E) cells, that 
separate the SVZ from the ventricular cavity (Lledo et al. 2006). Type B cells 
are slow cycling cells lining the border between the striatum and the lateral 
ventricle and expressing the astrocytic marker glial fibrillary acidic protein 
(GFAP). Type B cells give rise to rapidly dividing intermediate progenitors, 
type C cells, that lose GFAP expression, and acquire distal-less homeobox-2 
(Dlx-2). From type C cells type A cells arise, expressing PSA-NCAM (poly-
sialylated neural cell adhesion molecule) and the neuroblast marker 
doublecortin (DCX) (Alvarez-Buylla and Garcia-Verdugo 2002). Neuroblasts 
leave the SVZ and move along the rostral migratory stream (RMS) in chains 
formed by glial cells before terminating into the olfactory bulb (OB), where 
they differentiate into granule and periglomerular interneurons (Doetsch et al. 
1999) (Figure 1). Herein integrated newborn interneurons make local contacts 
and modulate sensory information. The current hypothesys is that they are 
involved in changes in the neural representation of an odor, thereby supporting 
long-term olfactory memory (Sultan et al. 2010). 
 




Figure 1.   Adult neurogenesis in rodent 
SVZ/olfactory systems undergoes four 
developmental stages. A schematic 
illustration of the adult mouse brain with 
an enlarged view of the olfactory system. 
Four developing stages define SVZ 
neurogenesis. Stage 1. Proliferation: stem 
cells in the SVZ of the lateral ventricles 
give rise to transient amplifying cells 
(type C cells). Stage 2. Fate specification: 
transient amplifying cells differentiate 
into immature neurons or neuroblasts 
(type A cells). Stage 3. Migration: 
immature neurons migrate in chains 
through the RMS to the OB. Stage 4. 
Synaptic integration: immature neurons 
differentiate into either granule neurons 
(orange) or periglomerular neurons (red), 
(Modified from Ming and Song 2005).  
 
 
Similarly, in the SGZ, stem cells termed type 1 cells, display a radial glial 
morphology and give rise to intermediate progenitors (type 2a and type 2b cells) 
which express neuronal specific markers before moving to the dentate granule 
cell layers where they integrate into the trisynaptic hippocampal circuit (Seri et 
al. 2001, 2004; Bonaguidi et al. 2012). The detailed developing process of adult 
hippocampal neurogenesis is described in the following section. 
 
In addition to neurogenesis occurring in the two forebrain regions, emerging 
evidence arose for a novel neurogenic site along the walls of the third ventricle, 
in the hypothalamic area. The hypothalamus is a small brain area that surrounds 
the third ventricle and contains distinct nuclei. It serves as a central homeostatic 
regulator of numerous physiological and behavioural functions, such as feeding, 
metabolism, body temperature, thirst, fatigue, aggression, sleep, circadian 
rhythms, and sexual behaviour. Several studies using 5-bromo-2'-deoxyuridine 
(BrdU) as well as genetic lineage tracing techniques reported constitutive 
neurogenesis in the adult hypothalamus of mammals, including rats and mice 
(Kokoeva et al. 2005; Pierce et al. 2010; Lee et al. 2014). Under unstimulated 
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conditions, the hypothalamus displays a low rate of neurogenesis and it is 
suggested that the de novo formation of newborn neurons might serve as a 
compensatory mechanism contributing to homeostatic control of dietary and 
energy balance (Yon et al. 2013). 
Within the adult hypothalamus, cells around the third ventricle form 
neurospheres, a hallmark of NSC. Cells like tanycytes, ependymocytes, 
subventricular astrocytes and parenchymal glial cells, all reside near the third 
ventricle and contribute to the neurogenic potential of the hypothalamus. 
Hypothalamic tanycytes constitute the main cell type lining the ventral third of 
the third ventricle, and resemble radial glia. Within the hypothalamus, tanycyte 
cell bodies are localised in the central and posterior hypothalamus, at the level 
of median eminence. Morphological studies have mapped and defined two 
subpopulations of tanycytes according to their position and process projection: 
i) β-tanycytes, lining the median eminence (ME); ii) α-tanycytes, extending into 
the arcuate nucleus (ARC) and ventromedial nucleus (VMN), lining the 
ventricular zone. Robins and colleagues (2013) have reported that α-tanycytes 
have NSC features and act as neural progenitors in the hypothalamus. It was 






tanycytes are self-renewing cells, that constitutively give rise to new tanycytes, 






Figure 2.   Distinc tanycyte populations line 
the hypothalamic third ventricle. Left hand 
panel: coronal section through third ventricle 
(3V), immunolabelled with Vimentin 
(intermediate filament marker, expressed by all 
tanycytes). The position and projection of the 
Vimentin
+
 process defines different tanycyte 
subsets: β-tanycytes line the median eminence; 
α2-tanycytes reside adjacent to the arcuate 
nucleus; α1-tanycytes extend from the level of 
the ventromedial nucleus to the dorso-medial 
nucleus. VMN, ventromedial nucleus; ARC, 
arcuate nucleus; ME, median eminence. 




1.1.1 Adult hippocampal neurogenesis 
 
Large efforts have been made in order to understand the function of adult-born 
neurons both in physio- and pathological conditions. The enormous interest in 
hippocampal neurogenesis was mainly due to the involvement of this brain 
region in cognition, and in particular in learning and memory (Aimone et al. 
2010). In the hippocampus, neurogenesis is localized within the SGZ in the 
dentate gyrus, where excitatory granule cells are continuously produced 
throughout life. The adult SGZ is a narrow band of cells made only of one to 
three nuclei. The SGZ contains the cell bodies of radial glia-like cells, with 
processes extending to the densely packed granular cell layer and to the 
molecular layer (Nicola et al. 2015). The DG has a complex local circuitry, with 
both inhibitory interneurons and excitatory feedback neurons (mossy cells) 
constituting the network. The sensory information from specific cortical areas 
converge to the entorhinal cortex and flows through medial and lateral perforant 
pathways to the dentate DG, then to CA3 pyramidal cells via mossy fiber axons 




of CA3 and back to the entorhinal cortex and subiculum regions, closing the 
“hippocampal loop” (Aimone et al. 2014). 
 
According to a recent publication by Kempermann and colleagues, adult 
hippocampal neurogenesis can be divided into four phases, defined as precursor 
cell phase, early survival phase, postmitotic phase and late survival phase 
(Kempermann et al. 2015) (Figure 3). The proposed model goes through 
different developmental stages, identified based on cell morphology and protein 
marker expression (Kempermann et al. 2004). In general, from a radial glia-like 
precursor cell, adult neurogenesis progresses throughout three identifiable 
progenitor stages to a postmitotic maturation phase ending with the formation 
of a mature granule cell.  
In the adult SGZ, four developmental stages define the precursor cell phase of 
NSPC pool expansion. In vivo clonal studies have revealed that radial glia-like 
precursors are multipotent stem cells capable of repeated self-renewal and 
generation of both neurons and astrocytes, but not oligodendrocytes, in the adult 
hippocampus (Bonaguidi et al. 2011). As it is, adult neurogenesis starts with a 
precursor cell population with morphological and antigenic properties of radial-
glia-like cells, named as type 1 cells. The type 1 cells express GFAP, astrocytic 
marker and nestin. The cell body of type 1 cells is found in the SGZ whereas 
the processes extends into the molecular layer. Type 1 cells show also 
electrophysiological properties of astrocytes (Filippov et al. 2003). One 
transcription factor specifically expressed in SGZ radial glia stem cells is the 
SRY-related HMG box family member Sox2, which plays a key role in stem 
cells self-renewal and is critical for the balance between proliferation and 
differentiation (Julian et al. 2013). The developmental potential of type 1 cells 
has been demonstrated with tracing experiments (Seri et al. 2004, 2001). Radial 
glial-like type 1 cells divide asymmetrically, with one daughter cell giving rise 
to the stem cell and another one giving rise to the intermediate progenitor, or 





Type 2 cells or transient amplifying progenitors, are highly proliferative cells 
with short processes, that are oriented tangentially to the DG. Type 2 cells come 
in two subtypes, both nestin positive. One subtype called type-2a cells still 
express the GFAP, but lack the radial glia morphology, the other cellular 
phenotype called type-2b, is positive for the immature neuronal marker DCX. 
Another recently added marker for type 2 cells, is the T-box brain protein 2 
(Tbr2), a transcription factor that identifies basal progenitor cells. Tbr2 is 
required for neurogenesis in the dentate gyrus of developing and adult mice. 
Tbr2 is critical for the transition from stem cells to intermediate progenitors, as 
it regulates Sox2 suppression (Hodge et al. 2008). Type 2 cells receive first 
synaptic GABAergic inputs, and respond to physiological stimuli, such as 
voluntary wheel running (Kronenberg et al. 2003) or pharmacological 
stimulation via serotoninergic-dependent mechanisms (Encinas et al. 2006) and 
GABA sets the pace for this regulation (Ge et al. 2007). Kempermann and 
colleagues propose that the fate choice decision occurs at the level of type 2a 
cells, given that already in type-2b cells there is expression of transcription 
factors NeuroD1 and Prox1, involved in neuronal fate choice (Kempermann et 
al. 2015). 
 
Type 3 cells are DCX positive, but nestin negative. DCX expression extends 
from a proliferative stage, through cell cycle exit, for a period of two to three 
weeks (Couillard-Despres et al. 2005). DCX also overlaps with PSA-NCAM 
expression.  
 
Next phase is the early survival phase. DCX expression still persists until next 
stage of newly formed neurons expressing the postmitotic marker NeuN and the 
transient Ca
2+ 
binding protein calretinin (Brandt et al. 2003). The majority of 
cells reaches this stage only three days after the initial division, then these 
immature neurons are subjected to a selection process, during which they can be 
eliminated or functionally recruited. Within few more days the number of 
NeuN
+




cells are eliminated before that the functional integration is established in the 
CA3 region and before receiving dendritic input from the enthorinal cortex, in 
the molecular layer. Cells that survive retain a vertical morphology with a 
rounded nucleus and the apical dendrite projecting toward the molecular layer. 
Then cells send out their axon to target CA3 region, in what is called the mossy 
fiber path. The main synaptic input to these cells is still GABAergic, and 
GABA remains excitatory (depolarizing), until sufficient glutamatergic contact 
has been made (Wang et al. 2000). GABA plays different roles in NPC and 
their progeny. The response to GABA is depolarizing in NPC and young 
neurons. In NPC this depolarizing effect is necessary for calcium influx, that in 
turn promotes the expression of NeuroD gene and leads to neuronal 
differentiation. The absence of a strong GABAergic inhibition in immature 
neurons represents an important property of these newborn cells. In acute brain 
slices newborn neurons exhibit enhanced synaptic plasticity, due to lower 
induction threshold and larger amplitude of long-term potentiation (LTP) of 
perforant path synaptic inputs compared with mature granule cells. It is 
suggested that regulation occurs at the survival phase, where only stimuli that 
are more specific to the hippocampus can affect it as it is for exposure to an 
enriched environment or to learning and memory hippocampus-dependent 
tasks, that are known to increase survival at this stage (Gould et al. 1999; 
Döbrössy et al. 2003). 
During the maturation phase, the depolarizing GABA has been shown to be 
critical for the maturation of adult-born neurons allowing the formation of 
glutamatergic synapses (Chancey et al. 2013). GABA remains depolarizing in 
young neurons until two week of age, which corresponds to the time in which 
glutamatergic spines develop on immature neurons. By 2.5 week of age young 
neurons have dendrites with spines and receive glutamatergic inputs. Once 
glutamatergic synaptic connections have been made, the new neurons go 
through a phase of late survival where increased synaptic plasticity occurs. 




increased inhibition, together with the onset of glutamatergic synapses, sets up a 
critical period for newborn neurons in memory encoding.  
The period of calretinin expression lasts for three to four weeks. Then newly 
formed cells switch the expression of calretinin to calbindin, that is found in all 
mature granule neurons (Brandt et al. 2003). At this time point the new neurons 
still require several additional weeks to become electrophysiologically 
indistinguishable from older granule neurons. 
 
 
Figure 3.   Developmental stages 
in the course of adult 
hippocampal neurogenesis. Panel 
A. Sagittal section view of an adult 
rodent brain and a detailed 
representation of the 
cytoarchitecture of the different 
layers of the hippocampus (hilus; 
SGZ; G, granular cell layer; ML 
molecular layer; area CA3 and CA1) 
and the hippocampal circuitry of the 
mossy fiber path connecting axonal 
projections of immature neurons to 
CA3 pyramidal cell layer; Schaffer 
collaterals (not shown) connect CA3 
axon projections to CA1, (modified 
from Ming and Song 2005). Panel 
B. The precursor cell stage is 
characterized by cells with radial 
glia-like morphology (Type 1 cells) 
and three putative transient 
amplifying progenitor cells (Type 2a 
and type 2b cells and type 3 
immature neuroblast). The early 
postmitotic phase is characterized by 
calretinin expression. The late 
postmitotic phase is characterized by 
terminally differentiated new 
granule cell, expressing calbindin. 
(Modified from Kempermann et al., 
2015) 
 
An intriguing question is about the functional importance of adult hippocampal 
neurogenesis. In other words, how newborn neurons contribute to adult brain 




levels of adult hippocampal neurogenesis with performances in hippocampus-
dependent tasks and thereby put a correlation link between neurogenesis and 
hippocampus-dependent processes of cognition and emotion. Adult 
hippocampal neurogenesis is a highly dynamic process, and many extrinsic 
positive modulators (i.e. enriched environment; physical activity; treatment with 
certain antidepressants; learning) have been reported to enhance performance in 
spatial navigation tasks (Morris water maze, MWM) and in tests of anxiety-
related behaviour (Kim et al. 2012). On the other hand, physio- and 
pathological conditions like aging, stress and inflammation, have been reported 
as negative regulators, and result in decreased performance in tasks of spatial 
navigation and emotion-related behaviour. Methodological advances in 
conditional gene targeting improved temporal and tissue specific control of 
NSPC and neuronal progeny. The primary function that has been mainly 
associated with adult neurogenesis is pattern separation and hippocampal 
newborn granule neurons contribute to dentate gyrus pattern separation. 
Behaviourally, mice in spatial discrimination tasks (i.e. radial-arm maze; two 
choice discrimination task) must discriminate between two spatially proximate 
stimuli. Patter separation is the ability to distinguish similar stimuli, and it is 
linked to discrimination tasks. In has been demonstrated by several groups that 
by manipulating the rate of adult neurogenesis, new neurons are critical for 
making discrimination between close spatial location or similar environments in 
tests of working memory and long-term memory (Lacar et al. 2014; Vadodaria 
and Jessberger 2014). In this contest, Sahay et al. (2011) reported that by 
boosting adult hippocampal neurogenesis, utilizing transgenic mice where the 
proapoptotic gene BAX is conditionally deleted in nestin-expressing NSPC 
(iBAX
nestin
 mice), enhances discrimination between similar contexts (Sahay et 
al. 2011). Thus, one of the current hypothesis is that adult hippocampal 
neurogenesis is critical for discriminating between highly dissimilar contexts, 
given that discrimination of proximal (in space) choices is selectively impaired 
without neurogenesis (two-choice discrimination task). Another possible role 




been shown to be suited to encode novel information better than the mature 
neurons (Aimone et al. 2006).  
 
1.1.2 The neurogenic niche 
 
The SGZ, as well the SVZ, form the proper microenvironment that is 
permissive for neurogenesis to occur. This microenvironment is called 
neurogenic “niche” (Morrens et al. 2012; Kempermann et al. 2015; Lin and 
Iacovitti 2015). Neurogenic niches can be defined as functional units within 
neurogenic areas, consisting of the stem cell pool, their progeny and the 
immature neurons, and other cellular components, like glial cells, microglia, 
and endothelial cells. The niche includes as well the extracellular matrix (ECM) 
and the vasculature and provides a milieu of non-cellular factors, such as 
secreted molecules and cell–to-cell contacts. All the components in the niche 
contributes to create a permissive microenvironment that tightly regulate 
neuronal development of the precursor cells. The local environment in the niche 
is pivotal in regulating the balance between self-renewal and multipotentiality 
maintenance for stem cells and for their progeny, and for controlling the 
different steps of lineage progression until the final commitment.  
The architecture within the niche of the SGZ and SVZ differs because it reflects 
the location differences of the two neurogenic areas (Lin and Iacovitti 2015) 
(Figure 4). The SVZ is located in proximity to the cerebral ventricles and along 
the anterolateral ventricle multi-ciliated ependymal cells (E cells) are located. 
The cilium of B stem cells protrude the E cell wall and senses the cerebrospinal 
fluid (CSF) in order to gain access to its components, whereas the SGZ does not 












made up the 
canonical 
neurogenic niches of 
SVZ (panel B) and 
SGZ (panel D). 
(modified from Lin 
and Iacovitti 2015) 
 
A key factor of both neurogenic niches is the vasculature that surrounds the 
stem cells. For this reason, the niche is often referred also as “neurovascular 
niche” (Palmer et al. 2000). The vessels of the neurovascular niche lack the 
astrocytic end feet and the tight junctions that are found in endothelial cells of 
other tissues. These results in a highly permeable blood-brain barrier in the 
niche site (Shen et al. 2008). As a consequence, NSPC have access to both local 
endothelial derived factors and to systemic factors (i.e. vascular endothelial 
growth factor – VEGF; brain derived neurotrophic factor – BDNF; signaling 
components like cytokines and chemokines, etc.) (Lin and Iacovitti 2015). 
 
Microglia are present in both SVZ and SGZ niches. They are considered 
important in regulating neurogenesis in both healthy and injured/diseased brain 
(Ekdahl 2012). The role of microglia in the niche includes phagocytosis. Sierra 
and colleagues (2010) showed that newborn cells undergoing death by 
apoptosis are rapidly cleared via phagocytosis by unchallenged microglia 
present in the adult SGZ niche (Sierra et al. 2010). In the healthy brain, 
microglia is also involved in synaptic elimination and pruning by phagocytic 
engulfment of synapses on mature neurons (Paolicelli et al. 2011) and by this 




al. 2010). Altogether these functions contribute to the establishment of proper 
connections for newly formed neurons. Conversely, microglial activation and 
release of proinflammatory cytokines, upon brain inflammation, has been 
associated with decline in neurogenesis (Pluchino et al. 2008). Therefore, 
microglial activation state determines different, even opposite, effects on adult 
neurogenesis. 
 
Astrocyte cells represent one of the major contributors of the neurogenic niches. 
Astrocytes have a broad diversity of subtypes, some behaving like stem cells 
(Seri et al. 2001) and some providing synaptogenic factors, that are critical for 
local dendritic spine maturation (Sultan et al. 2015). It has been shown that 
astrocytes also provide neurogenic signals, by instructing neural precursor cells 
to adopt a neuronal phenotype (Lim and Alvarez-Buylla 1999; Doetsch et al. 
1999; Song et al. 2002). Astrocytes of the SGZ are coupled by gap junctions 
and create what is called the glial syncytium, by which they propagate signals 
and may regulate activation and differentiation of the stem cell pool. It has been 
shown that abolishment of gap junctions coupling, via inducible or constitutive 





 mice), results in a dramatic decrease in the 
proliferation of precursor cells and in the percentage of newly born granule 
neurons (Kunze et al. 2009).  
 
ECM molecules (i.e. laminin; heparan sulfate proteoglycans - HSPG; etc.) are 
also important because they modulate the signals coming from the surrounding 
parenchyma and blood vessels. Stem cells have laminin receptors (i.e. integrins) 
on their surface that interact with components of the basal lamina and this 
interaction helps stem cells to orient in the niche (Erickson and Couchman 
2000). Moreover, HSPG of the matrix bind to mitogens like FGF, thereby 
regulating neurogenesis via ECM/growth factors interactions in structures 




Astrocytes also contributes to the production of the ECM. Thrombospondins 
(TSP) are a family of astrocyte-secreted proteins that are components of the 
ECM. Previous work suggested that TSP may play a role in hippocampal 
synaptogenesis. In particular, TSP-1 has been included in the key neurogenic 
factors released by astrocytes, given that TSP-1 is able to enhance precursor cell 
proliferation and neuronal differentiation (Hughes et al. 2010; Lu and Kipnis 
2010). In the neurogenic niche, astrocytes are as well a source of other 
important justacrine/paracrine signals (Notch; sonic hedgehog – SHH; bone 
morphogenetic proteins - BMP), neurotrophic factors (FGF2; BDNF; VEGF) 
and cytokines (Interleukine-1β - IL-1β; Interleukine-6 - IL-6). An interesting 
molecule, secreted by astrocytes is the high-mobility group box 1 (HMGB1) 
protein. HMGB1 is a common proinflammatory cytokine mediating 
inflammation, neuronal apoptosis and tissue damage. However emerging data 
suggest that HMGB1 appears to have beneficial effects in brain development, as 
it is associated with neurogenesis, in NPC survival, proliferation and neuronal 
differentiation via NF-B signaling (Meneghini et al. 2013; Li et al. 2014). 
Altogether astrocytes may be considered as crucial contributors to neurogenic 
permissiveness and their contribution in CNS and neurogenesis is deeply 
discussed in the following section. 
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1.2 Astroglia in the central nervous system 
 
Astrocytes are a heterogeneous cell population and represent the most abundant 
cells in the mammalian brain. Astrocytes exist in several morphologically 
different types all bearing multiple stellate processes. In the morphological 
classification the following phenotypes are included: i) the protoplasmic 
astrocytes (localized in brain grey matter), that provide para-arterial influx of 
nutrients, and para-venous clearance of toxic metabolites, with their 
perivascular endfeets; ii) the fibrous astrocytes (in brain white matter), involved 
mainly in the repair of damaged tissue; iii) the radial astrocytes that are the first 
developing cells from NSC during early embryogenesis and form a scaffold for 
neuronal migration and, after maturation, became stellate astrocytes. In the 
mammalian CNS astrocytes undergo differentiation from the NSC pool with the 
peak of astrogliogenesis occurring during late prenatal/early postnatal 
developmental (P1 to P10 in rodents), once the bulk of neurogenesis has 
occurred (Liddelow and Barres 2015). This switch from a largely neurogenic to 
a gliogenic potential of the NSC pool, reflects the temporal separation in the 
production of neurons versus astroglia. The increase in the number and 
complexity of glia during evolution suggests a possible function for astrocytes 
in human cognition (Molofsky et al. 2012). From an evolutionary point of view, 
both number and complexity of astrocytes increased. Invertebrates CNS 
contains only 20% of astrocytes, whereas human astrocytes constitute up to 
50% of CNS cells, contacting up to 10-times more synapses than their rodent 
counterparts (Oberheim et al. 2009). Thus, human cortical astrocytes have a 
more complex branching profile than those of rodents. Given the astrocyte 
dimension in the human brain, Sloan and Barres (2014) raised the hypothesis 
that information processing and circuit organization modulated by astroglia may 
contribute to improved human cognitive abilities. Conversely, human 
neurodevelopmental disorders may represent an end-product of disrupted 
astrocyte development (Sloan and Barres 2014). 
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Originally astrocytes were considered mainly as passive bystanders, playing 
critical functions in energy metabolism, K
+
 buffering and neurotransmitter 
recycling finalized to keep brain homeostasis. Nowadays, astrocytes cannot be 
considered anymore only as sustaining cells in the CNS, providing only 
metabolic and trophic support and passively maintaining neurons (Banker 
1980). Great interest grew for the role of astrocytes in regulating neuron-glia 
interaction, in order to control several processes of brain development, like 
neurogenesis and differentiation (Barkho et al. 2006; Lim and Alvarez-Buylla 
1999; Song et al. 2002), synapses formation (Pfrieger and Barres 1997) 
neuronal migration/axon guidance (Anton et al. 1997) and neuronal signaling 
(Fróes et al. 1999), all aspects that provide metabolic and electrophysiological 
interconnections between neurons and astrocytes. A vast array of data proves 
the importance of astrocyte-derived soluble factors in several steps of neuronal 
morphogenesis, ranging from precursor cell proliferation to neuronal 
differentiation and circuit formation (Gomes et al. 2001). Recently, the 
metabolic coupling between astrocytes and neurons has been considered to be 
essential for memory formation. The high metabolic demand for long-term 
memory formation is possible because astrocytes provide to neurons lactate as a 
source of energy, that is essential for long-term but not short-term memory 
formation, for synaptic plasticity and LTP (Suzuki et al. 2011).  
Emerging evidence support the concept of regional differences in glia/neuron 
ratio across the different mammalian brain areas (Herculano-Houzel 2014). This 
issue highlights how important for brain physiology and function must be the 
interaction between glial cells and neurons. 
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1.2.1 Astroglial phenotypes in health and disease 
 
Astrocytes become reactive and undergo reactive astrocytosis/astrogliosis in 
response to a vast array of CNS insults and the related mediators (such as 
cytokines and chemokines released from damaged surrounding neurons and 
active microglia) or in chronic neurological CNS diseases associated with 
aging, like Parkinson’s, Huntington’s and Alzheimer’s diseases (Sofroniew 
2015). In response to tissue damage or inflammation, the category of scar-
forming astrocytes form scar borders that segregate the damaged tissue in the 
CNS. This scar-forming astrocytes demarcate the compartment where damage 
(trauma, stroke, or infection) has occurred, meanwhile preserving the adjacent 
tissue. Conversely, in response to mild or diffuse CNS insults, or in tissue that 
are adjacent to scar borders, astrocytes undergo hypertrophic reactive 
astrogliosis. The changes that are associated with hypertrophic astrogliosis vary 
with the nature of the triggering insult, the CNS region involved, the distance 
from the insult itself, and the presence of co-morbid peripheral infections 
(Khakh and Sofroniew 2015). Under these circumstances, reactive astrocytes 
display hypertrophic cell body and nucleus, and the expression of characteristic 
marker of astrocytes, like GFAP and S100β is upregulated. Reactive astrocytes 
are involved in neuroinflammatory processes through the release of 
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I focused on two specific astrocytic players. 
 
i)  Lipocalin-2 (LCN-2) 
LCN-2 is a 24-kDa secreted protein, described first as neutrophil gelatinase-
associated lipocalin (NGAL) and also known as 24-kDa superinducible protein 
(24p3). LCN-2 is a member of the lipocalin family of proteins, known to bind 
and transport hydrophobic molecules (Flower et al., 2000). LCN-2 acts as a 
carrier/transporter and binds to two distinct cell-surface receptors: brain type 
organic cation transporter (BOCT/24p3R), that is expressed constitutively and 
interestingly is present at high levels in astrocytes; megalin receptor, that is 
expressed in a wide variety of tissues and cell types, such as ependymal cells; 
neural progenitors in mice spinal cord; oligodendrocytes, neurons and cultured 
astrocytes (Lee et al., 2015).  
LCN-2 has been implicated in a vast array of cellular processed ranging from 
cell death/survival (Devireddy et al., 2005), cell migration/invasion in cancer 
(Yang and Moses, 2009), cell differentiation (Bolignano et al., 2010). In 
physiological conditions LCN-2 is reported to have high affinity to bind and 
transport iron, therefore it modulates iron content into cells and this impacts on 
cell homeostasis (regulating proliferation versus apoptosis). Iron-containing 
(holo-) LCN-2 binds to 24p3R and is internalized, thereby increasing 
intracellular iron concentration. Instead, when the iron-free (apo-) LCN-2 is 
internalized upon 24p3R binding, it chelates iron and transfers it in the 
extracellular milieu, thereby impacting on cellular apoptosis (Devireddy et al. 
2005) (Figure 5). As well, LCN-2 can transport iron when complexed with 
siderophores. This binding confers the ability to LCN-2 to work as part of the 












Figure 5.   Potential effects of LCN-2 iron binding activity on cellular homeostatsis.  
A. Holo-24p3/LCN-2 containing the iron complex of the bacterial siderophore, donates 
iron to cells via the 24p3 receptor. Internalization of LCN-2 and its receptor leads to the 
uptake of iron from the siderophore-iron complex. Donation of iron to the cell leads to a 
decrease in TfR1 (Transferrin receptor protein 1) expression and an increase in ferritin 
levels. In addition, donation of iron to the cell prevents apoptosis by decreasing the 
expression of the proapoptotic protein Bim. B. Apo-24p3/LCN-2 binds to 24p3R and is 
internalized into the cell. Devireddy and colleagues (2005) suggest that a putative 
intracellular mammalian “siderophore iron complex”, called catechol, becomes bound 
to apo-24p3 to form holo-24p3, which is subsequently released from the cell by 
exocytosis. Depletion of iron from the cell results in the upregulation of the 
proapoptotic molecule, Bim, which leads to apoptosis (Richardson 2005). 
 
Initially, LCN-2 was proposed as an acute phase protein also in glial cells, 
based its role in the regulation of astrocyte death, morphology and migration. 
LCN-2 can be secreted by reactive astrocytes under inflammatory brain 
conditions. In astrocytes, released LCN-2 acts as an autocrine mediator of 
reactive astrocytosis. Following exposure to LCN-2, it was reported that, in 
parallel to increased GFAP immunoreactivity, there are also phenotypic 
changes in the number and lenght of cellular processes of astrocytes (Lee et al., 
2015). LCN-2 upregulation also promotes astrocytes migration via release of 
chemokine ligand-10 (CXCL10), chemokine that promotes the migration of 
other CNS cell types. Altogether LCN-2 upregulation is consistent with the 
hallmarks of reactive astrocytes.  
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In the CNS, LCN-2 expression is described to occur in response to injury or in 
inflammatory conditions. On the other hand, Chia and colleagues (2011) 
reported the distribution and the expression of LCN-2 in normal rat brain in 
physiological conditions, with low levels of expression in most brain regions, 
comprising the hippocampus, and highest levels of expression in olfactory 
bulbs, brainstream and cerebellum (Chia et al. 2011). They reported that LCN-
2
+ 
cells co-localize with GFAP
+ 
astrocytes of these regions.  
 
In addition, in the CNS, LCN-2 has been suggested to play a modulatory action 
in cognitive functions (Ferreira et al. 2013), neuronal excitability and anxiety 
(Mucha et al. 2011) and depression in human beings (Naudé et al. 2013). 
 
Interestingly, LCN-2 null mice (LCN-2
-/-
) display anxious and depressive-like 
behaviors, cognitive impairment in spatial learning tasks and in parallel 
synaptic impairment in hippocampal long-term potentiation (Ferreira et al. 
2013). Altogether behavioral studies, performed in order to assess animal 
anxiety-like behavior (i.e. elevated plus maze; light/dark box; open field test; 
Morris water maze), associated with hippocampal morphological analysis 
support the involvement of LCN-2 in emotion and cognition.  
 
Recently, Mucha and collegues (2011) reported that both Lcn2 gene and the 
encoded protein are upregulated in the hippocampus of male mice upon 
psychological stress (6h/daily restraint for 3days) and that LCN-2 contributes to 
stress-induced neuronal plasticity (Mucha et al., 2011). On one hand, they 
demonstrated through in vitro experiments that treating hippocampal neurons 
with lipocalin-2 (100 ng/ml), as an attempt to mimick stress induced 
upregulation, caused a decrease of mushroom spines (known as “memory 
spines”) and a concomitant increase of the thin spines (known as “learning 
spines”) in neuronal cultures. On the other hand, they observed that disruption 
of the Lcn2 gene in mice, caused an increase in the percentage of mushroom 
spines and their density. These ex vivo data correlated also with higher anxious-
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like behavior of LCN-2
-/-
 mice upon stress. This scientific report suggested that 
lipocalin-2 might regulate brain allostasis, and act as a mechanism of cellular 
adaptation in response to harmful stimuli.  
 
ii) Thrombospondins (TSPs) 
TSPs are astrocyte-secreted glycoproteins, that participate in a vast array of 
biological functions as part of the ECM, and regulate cell-cell and cell-matrix 
interactions. The TSP family consist of two subgroups. Subgroup A includes 
TSP-1 and TSP-2, whereas subgroup B includes TSP-3/4/5 (Figure 6). 
 
Figure 6.   Thrombospondin isoforms and 
oligomerization states. TSP can be divided into two 
subgroups. TSP-1 and -2 (subgroup A) form trimers, 
whereas TSP-3, -4, and -5 (subgroup B) are assembled 
as pentameric proteins. All TSPs contain a variable 
number of epidermal growth factor (EGF)-like repeats 
(blue) that are contiguous with calcium binding repeats 
(gray) and a globular conserved C-terminal region. A 
distinctive characteristic of group A TSP is the presence 
of a pro-collagen (von Willebrand factor, red) homology 
domain and the three properdin-like repeats (orange). In 
contrast, the pentameric thrombospondins (TSP-3, -4, 
and -5) lack the procollagen homology domain and the 
properdin-like repeats and contain four (instead of three) 







Recently, it was demonstrated that TSPs promote the formation of new 
excitatory/gabaergic synapses in the developing CNS. This process is called 
synaptogenesis and is stimulated by astrocyte-secreted prosynaptogenic signals, 
such as TSP, and not only controlled by intrinsic neuronal mechanism (Risher 
and Eroglu 2012). Excitatory synaptogenesis occurs in the mammalian brain 
after birth, and in rodents this period occurs during the second/third postnatal 
weeks. TSP-1 and TSP-2 were found to play active roles by promoting the 
formation of excitatory synapses, and their deficiency resulted in reduced 
synaptic density during development (Liauw et al. 2008). The increase in 
synaptogenesis is mediated by the interaction between the TSP EGF-like 
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domains (common to all TSPs) and the α2δ-1 neuronal receptor (Eroglu et al. 
2009). 
Considering the critical role of TSPs in developmental synaptogenesis, it was 
also discovered that these ECM proteins are upregulated/downregulated in 
response to CNS injuries and in several neuropathological disorders. The role of 
TSPs was investigated in stroke recovery. It was reported that TSP-1/2 double 
KO mice exhibited significant reduction in synaptic density, as well as 
significant deficits in their ability to recover functions. Instead in WT mice 
TSP-1 and TSP-2 mRNA and protein expression levels increased following 
stroke and the proteins were found to be co-localized primarily in astrocytes 
(Liauw et al., 2008). These studies suggest that deficiency in TSP-1 and TSP-2 
leads to impaired recovery after stroke and that TSPs are beneficial in term of 
synaptic formation. Altered TSPs expression has been reported in many 
neurological disorders. Down's syndrome (DS) is the most common genetic 
form of mental retardation and characterized by a reduced number of dendritic 
spines. DS astrocytes were found directly involved in the development of spine 
malformations and reduced synaptic density. This DS neurological feature has 
been linked to TSP-1 decreased protein expression in astrocytes (Garcia et al. 
2010).  
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder 
characterized by impaired cognitive function and memory loss due to deposition 
of senile plaques (Amyloid-β), neurofibrillary tangles, loss of neurons, 
microgliosis and astrogliosis. Along with these features the clinical stage is 
characterized by massive synaptic loss that correlates with cognitive decline in 
AD patients. It has been demonstrated that TSP-1 expression levels are 
significantly decreased in brain of AD patients and in two AD mouse models 
(Tg2576 mouse model, expressing Aβ precursor protein - APP, Swedish 
mutation K670N; and Tg6799/5xFAD mouse model, overexpressing mutant 
human APP695 with the Swedish, Florida I716V , and London V717I familial 
AD mutations, as well as human Presenillin 1 harboring two familial mutations 
M146L and L286V), (Son et al. 2015). This authors demonstrated that TSP-1 
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plays a protective role against Aβ toxicity on dendritic spines. Aβ1-42 was found 
able to regulate TSP-1 secretion levels in astrocyte and only TSP-1 was found 
reduced in astrocyte secretome. Furthermore, co-incubation of TSP-1 with Aβ1-
42 -treated hippocampal neurons, was shown to mitigate the dendritic spine loss 
via interaction with the TSP-1 receptor α2δ-1 in vitro.  
 
Lu and Kipnis (2010) proposed TSP-1 as key regulator of NPC self-renewal and 
neuronal differentiation in vivo and in vitro (Lu and Kipnis 2010). The authors 
showed that deficiency of TSP-1 impairs cell proliferation and neuronal 
differentiation, both in vivo and in vitro. First, by quantifying BrdU and Ki67 
proliferation markers in the neurogenic SGZ and SVZ areas in WT and TSP-1
-/-
 
mice (on a B6129SF1/J background), they reported a significant reduction in 
proliferating cells in mutant mice. In addition, in the same regions they 




 cells in TSP-1
-/-
 
mice compared with the WT counterparts. In the in vitro study, the authors 
confirmed that TSP-1 deficiency impairs cell proliferation and neuronal 
differentiation of SVZ-derived NPC. For the first time they demonstrated that 
incubation with exogenous TSP-1 (2 µg/ml) promotes WT NPC neuronal 
differentiation and that TSP-1
-/-
 astrocytes are unable to promote neuronal 
differentiation of NPC. Altogether these observations suggest that TSP-1 is one 
of the astrocytes-derived molecules required for astrocyte induced neuronal 
differentiation.  
 
Our group demonstrated that adult hippocampal NPC derived from wild type 
animals do express the α2-δ subunit of the voltage-gated calcium channels, and 
this receptor mediates the proneurogenic effect of antiepileptic drugs, 
pregabalin and gabapentin (Valente et al., 2012). 
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1.2.2 Astrocytes as modulators in adult neurogenesis 
 
Astrocytes, as influential components of the neurogenic niches, can contribute 
to regulation of new neurons formation. An active role for astrocytes and 
astrocyte-secreted factors in neurogenesis, has been demonstrated in the last 
two decades. The group of Gage was among the first ones to provide evidence 
for the active and instructive role of astrocytes in the adult brain (Song et al. 
2002). These scientists showed that hippocampal-derived astrocytes from 
postnatal mice actively regulate neurogenesis, instructing the adult stem cells to 
a neuronal fate commitment. They examined the fate choice of adult 
hippocampi-derived neural stem cells in vitro, establishing a co-culture system 
where NSPC were plated onto a feeder layer of primary hippocampal astrocytes 
from neonatal rodent brain. Furthermore, they showed that even adult 
hippocampal astrocytes retain the ability to promote neurogenesis from adult 
NSPC but are less effective compared to neonatal astrocytes. By examining the 
effects of astrocytes derived from neonatal and adult spinal cord, an area where 
multipotent stem cells can be isolated, they demonstrated the lower magnitude 
of neuronal differentiation of adult NSPC in presence of neonatal astrocytes. 
Conversely, astrocyte derived from adult spinal cord were ineffective in 
promoting neurogenesis, while were effective in promoting glial over 
neurogenic fate, data confirmed also by others (Lie et al., 2002). These results 
suggested for the first time the possibility that astrocytes from different CNS 
regions may provide regionally specific cues and that astrocytes at different 
developmental stages may exhibit different effects on NSPC fate choice.  
 
Previously, in a similar work, Lim and Alvarez-Buylla reported that the 
interaction between NPC derived from adult SVZ and astrocytes is necessary to 
stimulate neurogenesis (Lim and Alvarez-Buylla, 1999). Given the 
ultrastructure of SVZ, with astrocytes in close contact with type B cells (slow 
cycling stem cells, GFAP
+
) and with type C cells (rapidly dividing intermediate 
progenitors, Dlx-2
+
), these researchers explored the possibility that astrocytes 
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provide a neurogenic microenvironment for SVZ cells. In their publication they 
showed that direct contact with astrocytes deriving from cortices supports the 
proliferation of SVZ precursor cells and the differentiation of these into type A 
neuroblasts (DCX
+
). They suggested that it is necessary the direct contact 
between astrocytes and precursor cells for neurogenesis to occur. When they 
tested conditioned medium from astrocytes, they observed that the medium 
does not support neurogenesis, suggesting that the soluble factors produced by 
astrocytes may be necessary but not sufficient.   
 
Later on the work by Song and colleagues was supported by the group of Zhao, 
who performed gene expression profiling studies on primary astrocytes isolated 
from different regions of the CNS. The gene expression analysis was performed 
on astrocytes isolated from regions with high plasticity, such as newborn and 
adult hippocampal astrocytes and newborn spinal cord astrocytes, shown to 
promote neuronal differentiation of adult NSPC, and on astrocytes isolated from 
the non-neurogenic area of adult spinal cord, known to inhibit neuronal 
differentiation (Barkho et al., 2006). Briefly, they demonstrated that astrocytes 
isolated from different brain areas have distinct gene expression profiles. They 
found out that neurogenesis-promoting astrocytes release interleukine-1β (IL-
1β) and interleukine-6 (IL-6), which are proinflammatory citokines, that could 
promote NSPC neuronal differentiation in combination with other factors, such 
as vascular cell adhesion molecule-1 (VCAM-1) and interferon-induced protein 
10 (IP-10). Instead, astrocytes isolated from the spinal cord express more 
insulin-like growth factor binding protein 6 (IGFBP6, a negative regulator of 
insulin-like growth factor II signaling) and decorin (proteoglycan that can 
inhibit transforming growth factor 2, TGFβ2) which negatively regulate 
neurogenesis. In fact, it was demonstrated that this factors inhibited neuronal 
differentiation in vitro when co-cultured NSPC and neurogenic astrocytes were 
treated with them. These authors proposed that the combo of factors secreted by 
astrocytes into the local microenvironment is affecting the neurogenic niche.  
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Recently, IL-6 was identified to promote neuronal, but not glial differentiation 
of adult hippocampal NPC when applied directly in culture, by increasing the 
fraction of class III β-tubulin (TUJ1
+
) cells (Oh et al., 2010). Furthermore, was 
observed that also the average length of TUJ1
+
 neurites was increased compared 
to vehicle-treated cells, and the effects observed were abolished when IL-6 was 
neutralized by anti-IL-6 blocking antibody. This recent study supported the 
work done by Barkho and colleagues (2006). 
While proinflammatory cytokines generally inhibit neurogenesis, the fact that 
neurogenesis-promoting astrocytes express higher levels of inflammation 
related proteins than neurogenesis-inhibiting astrocytes, suggests that cytokines 
and chemokines may have context- and concentration-dependent effects.  
Astrocytes have been shown to secrete many positive, as well as negative 
modulators of hippocampal neurogenesis. Neurogenesin-1 (Ng1) has been 
identified as an astrocyte-derived soluble factor that positively modulate 
neuronal differentiation both in vitro and in vivo (Ueki et al., 2003). Ng1 has 
been found prominently expressed in neurogenic brain areas and co-localize 
mainly within astrocytes of the SGZ of the adult brain. The implication of Ng1 
in adult neurogenesis was confirmed by in vitro experiments on hippocampus-
derived NSC cultures. In these experiments, Ng1 neurogenic effect was 
antagonized with a neutralizing antibody against-Ng1 applied to NSC cultures 
prior to treatment with the supernatant of hippocampal neurogenic region. Thus 
this work supported the concept that astrocytes from the hippocampus 
contribute to the favorable environment for adult neurogenesis.  
Among other positive modulators, components related to glial metabolism also 
appear to be key regulators of adult hippocampal neurogenesis. ATP released 
from astrocytic metabolism, has been identified as a proliferative factor 
required for astrocyte-mediated NSC proliferation in the adult hippocampus and 
in vitro (Cao et al., 2013). Similarly, Sultan and colleagues reported that D-
serine a secreted astrocyte gliotransmitter abundant in hippocampal astrocytes, 
is able to increase the number of NSPC in vitro and when administered 
exogenously, it increases both the number of RGL cells and the number of 
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transient amplifying progenitors in the dentate gyrus of adult mice (Sultan et al., 
2013). Additionally the reduction of glutamine levels with fluorocitrate, that 
selectively inhibits glial metabolism, results in decreased levels of NPC 
proliferation (Fonnum et al., 1997).  
An interesting protein is the neurotrophin brain-derived neurotrophic factor 
(BDNF), that has been reported to regulate adult hippocampal neurogenesis 
(Waterhouse et al., 2012). Exogenous BDNF injection into the hippocampus 
boost NPC proliferation in vivo and promotes the differentiation and maturation 
of adult NPC in culture. This is consistent with evidence that neurogenesis 
decreases in BDNF knockout mice. SGZ-derived NPC have been demonstrated 
to express BDNF-TrkB receptor, that is required for the neurogenic and 
behavioral response to antidepressive treatments, supporting the concept that 
SGZ-derived NPC are a required component in the amelioration of depression 
(Li et al., 2008). Studies have demonstrated that hippocampal astrocytes 
minimally produce BDNF (Rudge et al., 1992). During aging the levels of the 
neurotrophin does not change, whereas those of the receptor TrkB decreases 
with increasing age, as reported in the rat hippocampus. This phenomen might 
be one of those correlated with aging-related decline in adult hippocampal 
neurogenesis.  
Instead, among the factors that are secreted by astrocytes and promote astroglial 
differentiation, there are bone morphogenetic proteins (BMP), that alter the fate 
of neural stem cells from neurogenesis to astrocytogenesis. BMP are members 
of the transforming growth factor β (TGFβ) superfamily, known to mediate the 
growth, differentiation and survival of different cell types (Dobolyi et al., 
2012). First studies reported that BMPs (BMP2/4/5/6) induce astroglial 
differentiation of SVZ-generated neural progenitors and the concurrent decrease 
of oligodendroglial and neuronal lineages, and this instructive effect is merely 
differentiative with no influences on both proliferation and survival of astroglial 
lineage cells (Gross et al., 1996). Other reports, demonstrated that NSC 
treatment with low-dose of BMP4 (0.1 ng/ml) or BMP7 (1 ng/ml) stimulates 
NSC to differentiate exclusively into neurons (TUJ-1
+ 
cells), with other cells 
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remaining undifferentiated, suggesting a concentration-dependent effect of 
BMP (Chang et al., 2003). Astrocytes secrete ciliary neurotrophic factor 
(CNTF), that is also important for differentiation of NSC into astrocytic lineage. 
CNTF alone (20 ng/ml) has a dramatic effect on astrocytic differentiation, with 
GFAP
+ 
cells > 90% of total cells. Interestingly, the combined treatment of the 
astrogenic/neurogenic BMP with CNTF results in a decrease in astrocytes and 
an increase in neurons. This demonstrates the context-dependent regulation of 
BMP, regardless its concentration (Chang et al., 2003). 
Furthermore, Ng1 involvement in neurogenic activity can be traced back to its 
structure (cysteine-rich domains), characteristic of BMP antagonists. Ueki and 
colleagues (2003) reported that Ng1 antagonize BMP-4 and alters that fate 
commitment of NSC from gliogenesis to neurogenesis, and suggests that Ng1 
may influence hippocampal plasticity by downregulating the activity of BMP 
(Ueki et al., 2003). 
Astrocytes supplement the local microenvironment also with mitotic factors and 
most notably FGF-2 and VEGF contribute to neurogenesis by enhancing the 
proliferation of NSC and their progeny both in the SVZ and SGZ. Bernal and 
colleagues (2011) asked whether a decreased availability of astrocyte-derived 
growth factors may contribute to the age-related decline in neurogenesis (Bernal 
and Peterson, 2011). GFAP-positive astrocytes express both VEGF and FGF-2. 
The authors found out that the gene expression levels of VEGF are significantly 
reduced in aged DG of rats compared to young one. In DG aging resulted also 
in the emergence of a phenotype of GFAP-positive astrocytes that did not co-
express FGF-2, whereas in the young brain all GFAP-positive astrocytes co-
localize with FGF-2. Anyway the overall density of astrocytes immunopositive 
for GFAP did not change. The authors suggested that the local environment 
during aging becomes less supportive for neurogenesis. VEGF and its receptor 
Flk-1 were detected also in Type-1 NSC and the co-expression of the two 
proteins is prior to neuronal commitment. Once DCX
+
 cells are formed, VEGF 
expression is lost, but Flk-1-mediated sensitivity to VEGF signaling is still 
maintained indicating that immature neuroblasts may be influenced by VEGF 
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signals presented by neighboring astrocytes. Normal aging is accompanied by a 
decline in CNS function and reduced neurogenesis. Astrocytes might be 
considered as the major contributors in maintaining the neurogenic niche given 
that the altered profile of astrocytes in the aged hippocampus negatively affects 
neurogenesis.  
 
In a recent publication a group of researchers investigated the neurogenic-
inducing properties of astrocytes isolated from cortical, hippocampal and 
midbrain areas, by analyzing the secretome profile of astrocyte conditioned 
media (ACM) and the effect on neuronal differentiation of human NPC 
(Cordero-Llana et al., 2011). They cultured human NPC for one and four weeks 
in control media or in regional-specific ACM. They demonstrated that ACM 
derived from hippocampus and midbrain is able to promote neuronal 
differentiation of human NPC, whereas ACM from cortex does not. By using 
mass spectrometry (MS) they identified clusterin as a protein secreted only in 
hippocampal and midbrain and not in cortex ACM. Clusterin is an interesting 
secretory glycoprotein (75-80 kDa), with high expression in astrocytes. It has 
no effect on the proliferation of NPC, but it promotes both their neuronal 
differentiation and survival. 
 
Generally, the control of NSPC proliferation and differentiation is influenced by 
several factors that are expressed by many cell types residing within the niche. 
The role of astrocytes on cell fate is different, with no clear knowledge of the 
instructive signals and the molecular pathways involved. Astrocytes are 
organizers of the neurogenic niche, and the signal they provide to the 
neurogenic process are a sum of complex microenvironmental cues, and 
influences of the surrounding cells. Astrocytes by releasing soluble factors, may 
play both instructive and permissive functions. On one hand astrocytes secreted 
molecules, may promote one fate at the expenses of another, on the other hand 
astrocytes cues may inhibit one fate, thereby allowing progenitors to 
differentiate in the other cell populations.   
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1.3 NF-κB signaling in adult neurogenesis 
 
The term NF-κB (Nuclear Factor kappa-light chain enhancer of activated B 
cells) refers to a family of transcription factors, firstly discovered in immune B 
cells to bind to the intronic enhancer of the kappa light chain gene, the κB site. 
These proteins are ubiquitously expressed and responsible for regulating the 
expression of multiple genes whose products are involved in pleiotropic 
functions, including cell survival/death, cell proliferation and differentiation and 
immune and inflammatory responses (Grilli and Memo 1999; Kovacs et al., 
2004; Vallabhapurapu and Karin 2009). Often NF-B signaling appears to play 
opposite functions, since the final outcome of its activation depends on the cell 
type involved, the type of disease or injuries and the target genes activated or 
repressed. NF-B signaling was initially studied mainly in the field of 
immunology, as major regulator of innate and adaptive immunity. In the CNS, 
NF-κB is expressed in both neurons and glia. In general, NF-κB in CNS glial 
cells, like microglia and astrocytes is mainly neurodestructive due to the 
overwhelming production of pro-inflammatory cytokines (Mattson and Meffert 
2006).  The role of NF-κB in the nervous system has gained interest because of 
its involvement in neuroprotection/neurodegeneration (Kaltschmidt and 
Kaltschmidt 2009), synaptic plasticity and neurite outgrowth (Gavalda et al. 
2009) and formation of functional dendritic spines (Boersma et al. 2011). On 
one hand many in vitro studies have demonstrated that neurotoxic and pro-
apoptotic stimuli including high concentrations of glutamate, amyloid-β or 
cytokines, cause NF-κB activation in neuronal cells, resulting in cell death 
(Uberti et al. 1999; Ryan et al. 2000; Zhang et al. 2005). On the other hand, it 
has been reported that neuron-restricted ablation of NF-B-driven gene 
expression promotes neurodegeneration (Fridmacher et al. 2003), suggesting a 
neuroprotective role for NF-κB. Recent finding, suggest that neuronal NF-B 
signaling is neuroprotective via maintaining neuronal survival, synaptogenesis, 
synapse to nucleus communication (Gutierrez and Davies 2011; Mattson and 
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Meffert 2006) and its role in regulating neural development and CNS functions 
such as learning and memory (Salles et al. 2014).  
Herein, I will introduce NF-κB family members and their signaling pathways, 
focusing on the emerging evidence of a role for NF-κB in regulating adult 
hippocamapal neurogenesis. 
 
1.3.1 The NF-κB family of transcription factors 
 
The NF-κB family of transcription factors is composed of five subunits 
including p50/p105 (NF-κB1), p52/p100 (NF-κB2), p65 (RelA), RelB and c-
Rel, which all share a conserved and multifunctional N-terminal Rel homology 
domain (RHD), that is responsible for homo- and hetero-dimerization of the 
different subunits. The RHD also contains nuclear localization signal (NLS), 
masked by binding of inhibitory IκB protein. Upon IκB inhibitory protein 
phosphorylation and degradation, NLS unmasking allows nuclear translocation 
of dimeric complexes which can then bind regulatory sequences in target genes. 
According to their structure, NF-κB family members can be divided into two 
subfamilies. One includes RelA, RelB and c-Rel, which are generally 
considered as transcriptionally activators, since they possess a transactivational 
domain (TAD), while the other subfamily includes p50 and p52 subunits, which 
are commonly considered as repressors, since lacking the TAD. The IκB family 
of inhibitors includes p100, p105, IκBα, IκBβ, IκBγ and Bcl-3. These inhibitors 
proteins are carachterized by the presence of ankyrin-repeat motives that 
mediate their binding with NLS/RHD of NF-B subunits. The p105 and p100 
C-terminal region, also containing ankyrin repeats, that acts like an auto-
inhibitory domain, retaining the precursors of p50 and p52, respectively, into 
the cytoplasm. (Figure 7) 
 




Figure 7.   Schematic diagram 
illustrating the mammalian 
members of the NF-κB and IκB 
families. NF-κB family members 
have in common the RHD, with 
RelA, RelB and c-Rel additionally 
possessing a TAD [RelB has a 
leucine zipper (LZ), while p52 
and p50 and their precursors have 
glycine-rich regions-(GRR); 
additionally, precursor possess 
regions with homology to death 
domains (DD)]. The ankyrin 
repeats of IκB members (denoted 
by green ovals), mediates the 
RHD binding. Within the IκBα 
phosphorylation sites relevant for 
regulation of NF-κB activation 
have been identified (Ser32, 
Ser36, Tyr42). (Gutierrez and 
Davies, 2011) 
 
At the cellular level, under unstimulated conditions, NF-κB dimers are retained 
in the cytosol through the interaction with a member of the inhibitory IκB 
protein family. The IκB subunit masks NLS in the NF-κB complex, thereby 
maintaining it in the inactive state. There is a variety of potential combinations 
for the NF-κB complex. In the CNS, the most abundant forms are the p65/p50 
heterodimer and the p50 homodimer, while IκBα is the most common inhibitory 
protein. A vast array of stimuli are able to trigger NF-κB activation by two main 
activating pathways, referred to as the canonical (or classic) and the non-
canonical (or alternative) pathways. The canonical NF-κB signaling pathway is 
crucial for the activation of innate immunity and inflammation. In response to a 
several proinflammatory cytokines, including tumor necrosis factor α (TNFα), 
interleukin-1β (IL-1β), and agonists of the toll-like receptor, such as 
lipopolysaccharide (LPS), the IκB Kinase (IKK) complex is activated via 
phosphorylation of consensus motives in the IκB members (IκBα, IκBβ, IκBε 
and p105). More specifically, phosphorylation on Ser32 and Ser36 residues of 
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IκBα by the IκB Kinase-β (IKKβ) catalytic subunit of the IKK complex 
(composed of IKKβ and IKKα, the catalytic subunits and the IKKγ, the 
regulatory subunit) triggers ubiquitination and proteasome-mediated 
degradation of the inhibitory protein. Once activated, the NF-κB p65/p50 dimer 
translocates into the nucleus, where it binds to the DNA consensus sequence of 
target genes. The non-canonical NF-κB signaling pathway is critical for 
adaptative immunity and is activated by some particular members of the TNF 
family (i.e. CD40L; Lymphotoxin-β). The non-canonical pathway involves NF-
κB inducing kinase (NIK)-induced phosphorylation of the IKKα subunit within 
the IKK complex, that in turn phosphorylates the p100 subunit of the 
heterodimeric complex p100/RelB. Following ubiquitination and proteasome-
dependent processing of p100 into p52, the nuclear translocation of the dimer 
RelB/p52 occurs and regulates target genes expression. A third distinct NF-κB 
signaling pathway triggered by DNA damage and oxidative stress, is defined as 
atypical because it is independent of the IKK complex (Viatour et al. 2005). 
Although in this pathway proteasome-mediated degradation of IκB is involved, 
the upstream kinases and the phosphorylation sites are different and, as of 








Figure 8.   Signaling pathways involved in NF-κB activation. In the canonical 
pathway, IKK complex activation leads to IκBs phosphorylation, followed by their 
ubiquitination and degradation by the proteasome, allowing the release of the 
heterodimer of p65/p50, which then translocates into the nucleus. The non-canonical 
pathway is dependent on NIK and IKKα, but not on the trimeric IKK complex, and 
mediates the activation of RelB/p52 complex. In the non-canonical pathway NIK-
induced phosphorylation of IKKα leads to the phosphorylation of p100 and 
proteasome-mediated processing of p100 into p52, allowing the nuclear translocation 
of RelB/p52 to regulate target gene expression. The atypical or IKK-independent 
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1.3.2 NF-κB signaling in the central nervous system: 
a role in synaptic plasticity, learning and memory 
 
In adult rodent brain all the DNA-binding subunits of NF-κB have been 
detected, with p50/p65 and p50/p50 dimers representing the most abundant 
forms (Kaltschmidt et al. 1993; Bakalkin et al. 1993; Schmidt-Ullrich et al. 
1996). It has been reported that constitutive NF-κB activity (that is in the 
nucleus, free of IκB and capable of binding DNA) has been detected in 
hippocampal neurons in vitro, as well as it occurs in vivo in several rodent brain 
regions, within neurons of neocortex, olfactory bulbs, amygdala, hippocampus 
and hypothalamus (Bhakar et al. 2002; Schmidt-Ullrich et al. 1996). This piece 
information supports a physiological role for NF-κB in maintaining survival or 
functions of central neurons. In addition, NF-κB acts also as a signal transducer, 
not only as a transcriptional regulator, by delivering transient signals from 
distant active synaptic sites to the nucleus, for example upon glutamatergic 
stimulation or depolarization (with potassium chloride or kainate) (Wellmann et 
al. 2000). This supports the concept that the activated transcription factor has a 
central role in translating short-term synaptic events into long-term gene 
expression changes (Kaltschmidt and Kaltschmidt 2009). 
Several studies based on genetic and pharmacological evidence have shown that 
NF-κB is implicated in the regulation of structural changes observed in synaptic 
connections and in controlling structural plasticity of neural processes (i.e. 
development, outgrowth, guidance and branching of axons and dendrites) 
(Gavalda et al. 2009; Salles et al. 2014), and that the signaling pathway is 
activated by the enhancement of synaptic activity (Meberg et al. 1996; Romano 
et al. 2006).  
 
Genetic studies associated with a variety of behavioural paradigms are in 
support for the role of NF-κB signaling in learning and memory. The 
availability of transgenic and knock out (KO) mouse lines for specific NF-κB 
subunits has been instrumental to research efforts aimed at a better 
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understanding of their specific role in CNS-related physiological and 
pathophysiological functions. Mice with a null mutation of p50 (p50
-/-
) show 
cognitive defects on novel task acquisitions (Kassed et al. 2002) and reduced 
short term spatial memory performance, without impairment of long term 
memory (Denis-Donini et al. 2008). However, the p50 subunit is a component 
of the transcriptional activator p65/p50 heterodimer, and a repressor in the 
p50/p50 homodimers, that lack the TAD. Therefore, some of the effects 
observed in p50
-/-
 mice might be due to the loss of p50 function as repressor as 
well as activator in combination with p65. Recently, the group of Albensi, 
found that the lack of the NF-κB p50 subunit led to significant decreases in late 
long-term potentiation (LTP) and deficits in long-term memory (Oikawa et al., 
2012), supporting the idea that p50 may also be required for spatial memory and 
long term plasticity. The deletion of p65 gene has been shown to be lethal 
during embryonic development, because of TNFα induced liver degeneration. 
To overcome this problems, the strategy of p65 deletion in association with 





-double KO mice) which survive postnatally (Alcamo et al., 
2001). These mice have normal brain cytoarchitecture but when analysed for 
memory performance using a spatial version of a radial arm maze, they showed 
selective learning deficits in spatial information storage (Meffert et al., 2003). 
These studies point out the role of NF-κB p50 and p65 in memory and 
hippocampal dependent tasks.  
 
LTP and long-term depression (LTD) are models of synaptic plasticity, believed 
to be the molecular correlates of memory formation and forgetting, since able to 
increase or decrease the synaptic efficacy, respectively (de la Fuente et al., 
2015; Snow et al., 2014). These paradigms are used to measure synaptic 
function and along with behavioral test of memory are used to assess 
hippocampal-dependent alterations in memory. In vivo, LTP induction increases 
the expression and the activation of NF-κB, with both p50 and p65 increase in 
the hippocampus in response to LTP (Meberg et al. 1996). Instead, the 
Chapter 1: Introduction 
43 
 
inhibition of NF-κB reduces LTP. This suggests that NF-κB is required for LTP 
induced synaptic plasticity, and that NF-κB activation is at the basis of synaptic 
changes occurring during memory storage. The dendritic spines, site of 
excitatory and inhibitory synapses on neurons, are dynamic structures with a 
high turnover during development, whereas throughout life the spine turnover 
continues at a low rate. The finding that instructive experience leads to spine 
stabilization, changes in spine density and increase in spine volume during LTP 
(Alvarez & Sabatini, 2007; Saneyoshi et al., 2010), have linked structural spine 
plasticity occurring in learning and memory with NF-κB signaling. 
 
As of today, many target genes being regulated by NF-κB in neurons have been 
discovered, and many of these genes are related to memory and plasticity. 
Those genes can be categorized in several groups. There are genes codifying for 
molecules involved in cell adhesion and growth, including neural cell adhesion 
molecule (NCAM) and β1-integrins, both controlling signals that induce neurite 
outgrowth during synaptic plasticity. Genes encoding for neurotrophins, such as 
BDNF, which results upregulated upon NF-κB activation in astrocytes and 
neurons and might be connected to cellular growth, differentiation and 
neurogenesis. Genes involved in cell signaling, such as protein kinase A (PKA). 
Kaltchmidt and colleagues (2006) reported that NF-κB regulates the 
PKA/CREB pathway that in turn controls spatial memory formation and 
synaptic plasticity (Kaltschmidt et al., 2006). Imielski and colleagues (2012) 
using a mouse model with neuronal specific ablation of NF-κB subunits 
(IκB/tTA mice - where neuronal NF-κB ablation can be established by 
CamKinaseII promoter-driven tetracycline controlled transactivator (tTA) 
regulating the expression of IκB in mice, where the transgene expression starts 
in type 2b DCX
+
 cells) reported that NF-κB controls the transcription of the 
forkhead transcription factor (FOXO1) and PKA kinase cascade, involved in 
axonal outgrowth (Imielski et al., 2012).  
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In glial cells, there is no constitutive activity of NF-κB, suggesting that NF-κB 
activation might be connected to pathological events. It is suggested that NF-κB 
signaling in astrocytes might regulate chemokine-induced infiltration of 
immune cell into lesioned brain (Kaltschmidt and Kaltschmidt 2009). 
Astrocytes have beneficial functions during the early stages of injury, whereas 
sustained activation of astrocytes enhances neuroinflammation. Astroglial-
derived mediators, like TNFα, recruit and enhance microglia⁄macrophage 
responses. This event is driven by astroglial NF-κB, which establishes an 
inflammatory intracellular environment. The group of Zheng and colleagues 
(2015) reported that in astrocytes, upon amyloid-β stimulation, there is a 
sustained activation of NF-κB, that leads to target upregulation and subsequent 
release of complement factor C3, which in turn, impairs neuronal function in 
Alzheimer’s disease (Lian et al., 2015). Dvoriantchikova and colleagues (2009) 
showed that the transgenic inhibition of astroglial NF-κB (using GFAP-IκBα-
dominant-negative mice, in which NF-κB is inactivated in astrocytes through 
overexpression of a dominant negative form of IκBα super-repressor under 
control of GFAP promoter) abrogates the establishment of the inflammatory 
cellular environment in a model of retinal ischemia-reperfusion injury 
(Dvoriantchikova et al., 2009). The same group reported that the transgenic 
inhibition of astroglial NF-κB has also neuroprotective effects in experimental 
autoimmune encephalomyelitis (Brambilla et al., 2009). Both publication 
demonstrate that selective inhibition of astroglial NF-κB significantly reduces 
the severity of the disease models. NF-κB role in astrocytes needs further 
investigation in order to explore the neuroprotective and and/or neurotoxic 
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1.3.3 NF-κB signaling in adult neurogenesis:  
in vitro and in vivo supporting data 
 
NF-κB family members are expressed in zones of active neurogenesis in the 
adult as well as in the postnatal mouse brain (Denis-Donini et al., 2005), 
suggesting that the signaling pathway may be actively involved in some of  the 
steps accounting for neurogenesis, such as proliferation, survival, migration and 
differentiation (Widera et al. 2008; Zhang and Hu 2012). Direct evidence of the 
presence of NF-κB in neurogenic zones has been validated by 
immunofluorescent microscopy (Meneghini et al., 2010). The group of Zhang 
and colleagues (2012) has shown that NF-κB signaling is required for NSPC 
initial differentiation (Zhang et al., 2012). They demonstrated that selective 
inhibition of canonical NF-κB subunits and blocking of the signaling pathway 
(by pharmacological stimuli, such as SN50 - a cell-permeable direct inhibitor 
for NF-κB nuclear translocation; or with small hairpin RNA (shRNA) 
knockdown of NF-κB subunits; or with NSPC-specific transgene dominant-
negative IκBα), it is possible to attenuate neural differentiation and enhance 




 NSPC (Zhang et al., 2012). Under 
physiological conditions, NF-κB is a crucial regulator of dentate gyrus tissue 
homeostasis (Imielski et al., 2012), however under pathological conditions, 
stress and/or aging, over-activation of NF-κB signaling could impair and reduce 
neurogenesis by depleting the hippocampal neural stem cell pool (Encinas and 
Sierra, 2012; Koo et al., 2010). 
Many additional studies have implicated NF-κB signaling in regulating 
neurogenesis during development and in the adulthood. Several extracellular 
signals have been identified as being able to affect NSPC via NF-κB activation. 
Several cytokines have been shown to regulate neurogenesis by stimulating NF-
κB signaling. IL-1β is a potent proinflammatory cytokine shown to mediate 
stress-induced depression via inhibiting adult neurogenesis. Koo and Duman 
(2008) reported that blockade of the IL-1β receptor (IL-1R1) by using either an 
antagonist or IL-1R1null mice (adult male IL-1R1 null mice bearing a C57BL/6 
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background) blocks the antineurogenic effect of stress. In the in vitro studies 
they demonstrated that hippocampal neural progenitor cells express IL-1β 
receptor-1 (IL-1R1) and that activation of this receptor decreases cell 
proliferation via the NF-κB signaling pathway (Koo and Duman, 2008). It has 
also been reported that IL-1β exerts also anti-proliferative, anti-neurogenic and 
pro-gliogenic effect on embryonic rat hippocampal NSPC, which is mediated 
by IL-1R1 (Green et al., 2012). On the contrary, the cytokine TNF-α was 
identified to trigger survival, proliferation, and neuronal differentiation from 
both adult rat and neonatal mice cultured SVZ NSPC, via NF-κB signaling in 
vitro (Widera et al. 2006; Zhang and Hu 2013). Other data suggest that TNF-α 
promotes gliogenesis but not neurogenesis (Ricci-Vitiani et al., 2006). A recent 
report suggests that the mechanism that may contribute to the neuroprotective 
activity of TNF-α is dependent on the regulation of Ephrin B2 gene by NF-κB 
pathway activation (Pozniak et al. 2013). Notwithstanding the negative effect of 
TNF-α on neuronal survival is dependent on the context, timing and dosage of 
its activity (Lenzlinger et al. 2001). Increasing interest has been devoted to 
another cytokine, interleukin-6 (IL-6), that has been shown to induce NSPC to 
differentiate specifically into glutamate-responsive neurons, as well as into 
phenotypically different glia types (Mukaino et al., 2008). Another example 
comes from studied from Wada and colleagues, who demonstrated that vascular 
endothelial growth factor (VEGF) directly promotes adult NSC survival (Wada 
et al., 2006). It was also demonstrated that VEGF can influence adult 
hippocampal neurogenesis and hippocampus-dependent memory (Licht et al., 
2011), and the different VEGF phenotypes were blocked by inhibition of the 
downstream effector NF-κB. Taken together, these data support the hypothesis 
that in physiological conditions or in early stages of injuries, transient NF-κB 
activation by these cytokines/GF, may be beneficial by promoting neural 
progenitor cells differentiation for neural repair or maintaining daily 
neurogenesis. However, chronic activation of NF-κB would result in the 
reduction of the pool of NSPC (Koo et al., 2010). These results emphasise the 
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influence of local environment on the differentiation of NSPC during 
development, 
 
Many receptors have been identified playing a pivotal role in NF-κB activation 
and NPC differentiation, upon ligand binding. Schwartz and colleagues, 
identified toll like receptors (TLR) as players in adult neurogenesis. TLR2 and 
TLR4 are found on adult NSPC and have distinct and opposing functions in 
NPC proliferation and differentiation both in vitro and in vivo. The activation of 
TLRs on the NPCs was mediated via activation of the NF-κB signaling pathway 
(Rolls et al., 2007). 
Among the upstream receptors that activate NF-κB signaling pathway in NPC 
of adult mouse hippocampal and SVZ neurogenic region, there is the receptor 
for advanced glycation end-products (RAGE). RAGE ligands, like the alarmin 
HMGB1, S100β and AGE-BSA, are able to stimulate both proliferation and 
neuronal differentiation of SVZ-derived NPC in vitro (Meneghini et al., 2010). 
It was also demonstrated that HMGB1 and Aβ1-42 oligomers, both involved in 
Alzheimer’s disease pathophysiology (Takata et al., 2003) are able to promote 
neuronal differentiation of adult hippocampal NPC via activation of the 
RAGE/NF-κB axis (Meneghini et al., 2013).  
 
Literature data supports the involvement of NF-κB signaling pathway in 
mediating the proneurogenic and antidepressant-like activity of some clinically 
relevant drugs. Increasing evidence demonstrate that neuroplasticity is disrupted 
in mood disorders and in animal models of depressive-like behaviour and it can 
be upregulated by antidepressant drugs (Pittenger and Duman, 2008; Hanson et 
al., 2011). An intriguing observation is that most antidepressant and 
environmental interventions (i.e. learning tasks; enriched environment; physical 
activity) that confer antidepressant like-behavioral effects also stimulate adult 
neurogenesis (Sahay and Hen, 2007).  
Our group recently identified novel positive modulators of hippocampal 
neurogenesis, as potential new antidepressant drugs, that require NF-κB 
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activation for exerting their proneurogenic effects in vitro and in vivo. The first 
example is represented by pregabalin (PGB) and gabapentin (GBP) that are 
clinically relevant anticonvulsant, analgesic and anxiolytic drugs. Our group 
demonstrated that GBP and PGB produce a concentration dependent increase in 
the number of mature and immature neurons in vitro, acting through the α2-δ 
subunit of the voltage-gated calcium channels, which was found to be expressed 
on adult hippocampal NPC (Valente et al., 2012). The activation of NF-κB is 
involved in the proneurogenic effect elicited by α2-δ ligands, because the 
inhibition of both p50 and p65 nuclear translocation of IKKβ counteracted 
drug-mediated effects. Moreover, PGB antidepressant like activity was 
confirmed in vivo in adult mice. The appearance of depressive-like behaviour 
induced by chronic restraint stress was prevented by administration of the drug, 
and in parallel promoted adult hippocampal neurogenesis (Valente et al., 2012). 
Another drug reported to have proneurogenic and antidepressant-like activity 
via modulation of NF-κB signaling pathway is acetyl-L-carnitine (ALC) 
(Cuccurazzu et al., 2013). Our group demonstrated that the drug-mediated 
effect on neuronal differentiation of adult hippocampal NPC in vitro, is 
dependent on the acetylation of p65 subunit and subsequent NF-κB-mediated 
upregulation of metabotropic glutamate receptor 2 (mGlu2). In addition, when 
tested in vivo, chronic ALC treatment significantly increased the number of 
adult born neurons in mouse hippocampi and reverted depressive-like behaviour 
induced by unpredictable chronic mild stress. 
 
Our group investigated the role of NF-κB p50 subunit in adult hippocampal 
neurogenesis by taking advantage of p50
-/-
 mice generated in the laboratory of 
David Baltimore (Sha et al., 1995). In this genetically modified animal model, 
we demonstrated a marked deficiency in neurogenesis in the hippocampus , as a 
result of a defect in the late maturation of newly born neurons (Denis-Donini et 
al., 2008). Interestingly, no defects have been observed in the rate of NSPC 
proliferation in the SGZ of p50
-/-
 animals compared to wt mice. However, the 
survival of neural progenitors after 21 days post BrdU injection was 
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significantly reduced in mutant compared to wt animals. A detailed phenotypic 
characterization of newly generated cells revealed no differences in the number 
of DCX
+
 neuroblasts, but a marked reduction in calretinin post mitotic neurons 
in the DG of p50
-/-
 animals. Based on this findings, our group proposed that the 
absence of the p50 subunit of NF-κB may trigger a selective defect in adult 
neurogenesis progression at the transition phase between neuroblasts and 
postmitotic neurons.  
p50
-/- 
mice were also evaluated at the behavioural level. When tested in the 
Morris water maze (MWM), wt and p50
-/- 
performed equally in the acquisition 
test, with normal retrieval of hippocampal-dependent spatial memory in the 
probe test performed 24h after the last training trial. Conversely, when wt and 
p50
-/-
 mice were subjected to the place recognition test for evaluating their 
ability to discriminate familiar versus a novel environment, the two genotypes 
performed differently. Specifically, p50
-/-
 mice showed a selective impairment 
in short-term spatial memory. The correlation between neurogenesis defects and 
deficits in short-term spatial memory performances deserves further 
investigation. 
Many other publications support the importance of NF-κB in synaptic plasticity 
and memory. The group of Albensi investigated the role of NF-κB in both 
synaptic plasticity and long term spatial memory in p50
-/-
 mice (Oikawa et al., 
2012). They used the same KO mice model to test if the absence of p50 
negatively affected in vivo MWM performance and in vitro LTP response. LTP 
is an experimental paradigm used to assess hippocampal-dependent alterations 
and measure synaptic function, and is commonly regarded as the molecular 
correlate of memory formation. Albensi’s group found that the lack of the NF-
κB p50 subunit led to a significant decrease in late LTP and in selective 
alterations in MWM test, with defects in long term spatial memory. Given these 
contradictory findings, open questions remain concerning the complex 
contribution of NF-κB p50 subunit in long versus short memory. 
The group of Imielski found out that NF-κB ablated mice (IκB/tTA mice) show 
a strongly increased number of activated astrocytes that is accompained with a 
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severe dentate gyrus atrophy. They proposed that this condition may rely on a 
dual function of NF-κB in the hippocampus. They suggest a cell autonomous 
role of NF-κB in axogenesis, with NF-κB being necessary for axogenesis and 
maturation in neuronal progenitors, whereas in mature granule cells NF-κB may 
play a distinct role by regulating neuroprotection as well as synaptic 
transmission. When NF-κB is inactivated, the dentate gyrus cannot be 
regenerated by the addition of new-born neurons (Imielski et al., 2012). 
Several studies that demonstrated increased hippocampal neurogenesis 
following hippocampus-dependent tasks, have established a connection between 
neurogenesis in the adult hippocampus and learning and memory. The 
deficiency in hippocampal neurogenesis and the selective defect in short term 
spatial memory performance in adult p50
-/-
 animals, provide evidence that NF-
κB-regulated hippocampal neurogenesis, can influence aspects connected to 
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Outline of the thesis  
 
Neurogenesis occuring during postnatal life in restricted to two selected regions 
in the adult brain of mammalians. The canonical and well-studied neurogenic 
sites are the subgranular zone (SGZ) in the dentate gyrus of the hippocampus, 
and the subventricular zone (SVZ) of the lateral ventricles (Ming and Song 
2005; Bond et al. 2015; Kempermann et al. 2015). Emerging evidence recently 
suggested a novel neurogenic site along the walls of the third ventricle in the 
hypothalamic area, whose features and functions are under investigation 
(Kokoeva et al., 2005; Robins et al., 2013).  
Large interest grew for hippocampal adult neurogenesis due to the involvement 
of this brain region in cognitive functions like learning and memory, processes 
relevant for human beings, as well as in emotional behavior and stress response 
(Aimone et al. 2010; Vadodaria and Jessberger 2014). 
Adult hippocampal neurogenesis (ahNG) is a highly dynamic and plastic 
process strictly connected to environmental changes. Many extrinsic modulators 
(i.e. learning, enriched environment, physical activity; antidepressants drugs) 
have been reported to enhance hippocampal neurogenesis and, in parallel, long 
term potentiation and cognitive performances, reversal of depressive-like 
behaviour and resilience to stress in mouse models (Hanson et al., 2011). On the 
other hand, physio- and pathological conditions like aging, stress and 
inflammation, as well as addictive drugs, have been reported as negative 
regulators which result in decreased neurogenesis and performance in tasks of 
spatial navigation and alteration in emotion-related behaviour (Lazarov et al., 
2010; Yirmiya and Goshen, 2011; Lucassen et al., 2015). Last, but not least, it 
is of great interest that hippocampal neurogenesis is deregulated in various 
neuropsychiatric disorders, such as major depressive disorder and anxiety, 
schizofrenia, and neurodegenerative diseases (Winner et al., 2011; Nath et al., 
2012; Schoenfeld and Cameron, 2015; Miller and Hen, 2015).  
Adult neurogenesis occurs in a permissive and instructive microenvironment 
referred to as the “neurogenic niche” where local environmental cues, both 
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membrane-associated and released by resident cells, interact with neural/stem 
progenitor cells (NSPC) and in turn affect their functionality (self-renewal and 
multipotential properties), their commitment and their survival. The niche is the 
result of the complex interplay among different cell types (NSPC, precursors, 
astroglia, microglia, neuroblasts), secreted molecules (i.e. cytokines, growth 
factors, secreted proteins), vasculature, and extracellular matrix (ECM) 
components (Lin and Iacovitti 2015). Cell-to-cell communication plays a key 
role in the homeostatic modulation of the neurogenic process under 
physiological conditions and also in response to damage in pathological 
conditions. Among the niche cellular components, astrocytes represent one 
important contributor which can instruct NSPC proliferation, affect the 
maintenance of their undifferentiated state, modulate their lineage 
differentiation through both contact-dependent interactions and secretion of 
soluble molecules. In addition, astrocytes can also influence maturation, 
survival and integration of newly generated neurons by providing signals which 
are critical for synaptogenesis and dendritic spine maturation (Song et al. 2002; 
Oh et al. 2010; Risher and Eroglu 2012). 
In previous publications our lab proved that members of the NF-B family of 
transcription factors are important contributors of signaling pathways in the 
SGZ neurogenic niche (Denis-Donini et al., 2005) and may be potentially 
involved in mediating the proneurogenic and antidepressive-like effect of some 
clinically relevant drugs (i.e. α2δ ligands, acetyl-L-carnitine) (Cuccurazzu et al., 
2013; Valente et al., 2012) and in the proneurogenic effects of damage- 
associated signals (i.e. HMGB-1 and Aβ1-2) (Meneghini et al., 2013). In the 
CNS NF-B is involved in neuroprotection/neurodegeneration, differentiation, 
migration, synaptic plasticity, and neurite outgrowth, all functions making this 
family of transcription factors potential candidates for translating complex 
signals that regulate the neurogenic process (Grilli and Memo, 1999; 
Kaltschmidt and Kaltschmidt, 2009; Bortolotto et al., 2014). Within the family, 
the p50 subunit appears to play a crucial role since p50KO mice display 
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dramatically reduced adult hippocampal neurogenesis which is in association 
with short-term memory defects (Denis-Donini et al., 2008). 
The main project for this PhD thesis developed from the observation that unlike 
in vivo, hippocampal NPC derived from WT and p50KO adult mice have 
similar rate of differentiation, proliferation and apoptosis in vitro. 
Based on these observations, in our first investigation, we exploited the 
advantages of using primary cell culture systems from WT and p50KO mice to 
investigate the contribution made by astrocyte conditioned media (ACM) under 
basal conditions, on adult NPC fate specification. In particular, we wanted to 
elucidate the involvement of astroglial cells in the defective hippocampal 
neurogenesis observed in vivo. In our in vitro experimental context, we 
analyzed the role of the NF-B pathway in the cross-talk between astrocytes 
and adult hippocampal NPC. For this purpose, we set up primary astroglial 
cultures, as well NPC cultures, from both WT and p50KO mice and analyzed 
the phenotypic commitment of WT/p50KO NPC when exposed to WT/p50KO 
astrocyte-conditioned media. On one hand, we attempted to identify the 
proneurogenic and/or antineurogenic signals that, under control of NF-B p50, 
may be differentially expressed in astrocytes. On the other hand, we also 
focused our attention on the possibility that absence of p50 may produce cell-
autonomous defects in NPC responsiveness to astrocytic-derived factors.  
An additional line of investigation was devoted to explore region-specificity in 
astrocyte-derived signals that may affect cell fate commitment of hippocampal 
adult NPC. In particular, we analyzed differences in the pro-neurogenic and -
gliogenic potential of hippocampal and hypothalamic astrocytes of both WT 
and p50KO origin. Additional work was performed with the purpose of 
understanding fate specification of hypothalamic WT NPC cultures in presence 
hippocampal ACM. 
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Abstract   
 
In previous work we demonstrated that NF-κB p50 acts as crucial regulator of 
adult hippocampal neural progenitor cells (ahNPC). Indeed, NF-κB p50KO 
mice are characterized by remarkably reduced hippocampal neurogenesis. As a 
follow up to that work, herein we show that when cultured in vitro, ahNPC from 
wild type (WT) and p50KO mice are not significantly different in their 
neurogenic potential. This observation prompted us to investigate cell 
autonomous and non-cell autonomous consequences of p50 absence on 
neuronal fate specification of ahNPC. In particular, we focused our attention on 
astrocytes, known to provide soluble proneurogenic signals, and investigated 
the influence of WT and p50KO astrocyte conditioned media (ACM) on WT 
and p50KO ahNPC differentiation. Interestingly, while WT ACM promoted 
both neuronal and astroglial differentiation, p50KO ACM only supported 
astroglial differentiation of WT ahNPC. By using a LC-MS/MS approach we 
identified several proteins which are significantly upregulated in p50KO 
compared to WT astrocytes. Among them, lipocalin-2 (LCN-2) was recognized 
as a novel astroglial-derived signal regulating neuronal fate specification of 
ahNPC. Interestingly, LCN-2 proneurogenic effect is greatly reduced in p50KO 
NPC. In addition, we demonstrated p50KO NPC unresponsiveness to both 
neuronal and astroglial fate specification signals from WT and p50KO ACM, 
and we identified reduced expression of α2δ1, a thrombospondin-1 receptor, as 
one phenotypic change occurring in ahNPC in absence of p50. Altogether our 
data suggest that reduced hippocampal neurogenesis in p50KO mice in vivo is 
to be ascribed to cell autonomous and, likely, to non-cell autonomous defects in 







    Adult neurogenesis occurs in restricted areas of postnatal and adult 
mammalian brain, namely the subventricular zone (SVZ) in the lateral wall of 
the lateral ventricles and the subgranular zone (SGZ) in the dentate gyrus (DG) 
of the hippocampus (Ming and Song, 2005; Bond et al., 2015; Kempermann et 
al., 2015). Recent studies also suggested an additional neurogenic region in the 
adult hypothalamus (Kokoeva et al., 2005; Whalley, 2012). 
    Adult hippocampal neurogenesis (ahNG) has attracted great research interest 
due to its potential involvement in critical functions including cognition, mood 
and emotional behavior, stress response (Aimone et al., 2010, 2014; Lacar et al., 
2014). The molecular mechanisms that modulate neurogenesis are very 
complex and deserve extensive investigation which may turn into a better 
understanding of homeostatic regulation of ahNG but also of 
neuropsychiatric/neurodegenerative disorders where this process is profoundly 
deregulated (Winner et al., 2011; Apple et al., 2016). 
    Within the CNS, NF-κB pathway activation has been involved in a wide 
range of functions both under physiological and pathological conditions (Grilli 
and Memo, 1999; Mattson and Meffert, 2006; Kaltschmidt and Kaltschmidt, 
2009). A few years ago our group demonstrated that NF-B proteins are 
expressed at considerable levels in areas of active neurogenesis in the postnatal 
and adult mouse brain (Denis-Donini et al., 2005). Since then, a vast array of 
information has been collected on the complex involvement of NF-κB proteins 
in different aspects of postnatal neurogenesis. In particular, several extracellular 
signals and membrane receptors have been identified as being able to affect 
neural stem cells/neural progenitor cells (NSC/NPC) and their progeny via NF-
κB activation (Wada et al, 2006; Rolls et al., 2007; Widera et al., 2008; 
Meneghini et al., 2010, 2013). 
Since the initial observations of NF-κB members being present in adult 
neurogenic areas, our group further explored the role of these regulatory 




(Grilli and Meneghini, 2012; Bortolotto et al., 2014). By taking advantage of 
p50KO mice (Sha et al., 1995) we demonstrated that absence of p50 can deeply 
affect the in vitro response of adult hippocampal NPC (ahNPC) to several 
endogenous signals (Meneghini et al., 2013), and to proneurogenic drugs 
(Valente et al., 2012). In vivo we also proved that p50KO mice display a 
dramatic reduction in adult hippocampal neurogenesis which correlates with a 
selective defect in hippocampal-dependent short-term memory (Denis-Donini et 
al., 2008). Interestingly, in vivo the proliferation rate of hippocampal NSC/NPC 
in p50KO mice appeared to be similar to that of WT mice. Similarly, the 
apoptotic rate in the hippocampal region was not increased in mutant mice 
compared to their WT counterpart. A detailed phenotypic characterization of 
newly generated hippocampal cells in p50KO mice suggested that absence of 
the NF-κB p50 subunit may trigger a rather selective defect in neuronal 
differentiation of ahNPC (Denis-Donini et al., 2008).  
Homeostasis of adult neurogenesis requires permissive and instructive 
signals for aNSC/NPC. Several elegant studies have investigated the 
mechanisms through which local environment in the neurogenic niche may 
control fate specification of aNSC/NPC (Schänzer et al., 2004; Bonaguidi et al., 
2005; Lu and Kipnis, 2010). Among others, a pivotal work by Song et al. 
(2002) demonstrated that astroglial cells are crucial regulators in the 
hippocampal niche, where they can instruct stem cells to adopt a neuronal fate 
(Song et al., 2002). Since the well documented role of NF-κB in neuronal but 
also in non-neuronal cells (Brambilla et al., 2009; Lian et al., 2015; de la Fuente 
et al., 2015), we recently decided to further dissect the role of NF-κB p50 in the 
cross-talk between adult neural progenitor cells and astrocytes. Exposure of WT 
and p50KO hippocampal NPC to conditioned media from WT and p50KO 
astrocytes was utilized as a strategy to study the potential influence of astroglia 
on adult NPC fate specification and the cell autonomous or non-cell 





Materials and Methods  
 
Animals. Wild type (WT; C57BL/6; The Jackson Laboratories) and NF-κB p50
-
/-
 (p50KO; C57BL/6 Nfkb1
tm1Bal
/J; The Jackson Laboratories) mice were housed 
under light- and temperature-controlled conditions in high-efficiency particulate 
air (HEPA)-filtered Thoren units (Thoren Caging Systems) at the University of 
Piemonte Orientale animal facility. Mice were kept 3-4/cage with ad libitum 
access to water and food. Animal care and handling were performed in 
accordance with European Community Directive and approved by the local 
IACUC (Institutional Animal Care and Use Committees). 
 
Isolation and culture of WT and p50KO adult mouse hippocampal neural 
progenitor cells (NPC). For preparing NPC primary cultures from hippocampi, 
three adult (3-4 month-old) male WT and p50KO mice were sacrificed and cell 
suspension was prepared. Briefly, the brains were removed, and hippocampi 
were isolated and collected in ice-cold PIPES buffer pH 7.4 containing 20 mM 
PIPES, 25 mM glucose, 0.5 M KCl, 0.12 M NaCl (Sigma-Aldrich), and 100 
U/100 µg/ml Penicillin/Streptomycin solution (Life Technologies). After 5 min 
at 110 x g centrifugation, the tissue was digested for 40 min at 37°C using the 
Papain Dissociation System (Worthington DBA). Cell suspension was plated 
onto 25 cm
2
 cell-culture flask (Thermo-Fisher Scientific) and cultured as 
floating neurospheres through subsequent passages (Valente et al., 2012). 
Primary (Passage 1, P1) neurospheres were dissociated after 7-10 days in vitro 
(DIV), whereas P2-P30 neurospheres every 5 DIV. At each passage cells were 
plated in T25 flask at a density of 12,000 cells/cm
2
 in growing medium: 
Neurobasal-A medium, supplemented with B27 supplement, 2 mM L-glutamine 
(Life Technologies), human Epidermal Growth Factor (hEGF, 20 ng/ml; 
Peprotech), basic Fibroblast Growth Factor (bFGF, 10 ng/ml; Peprotech) and 





Adult hippocampal NPC differentiation. NPC (P5-P30) were used for 
differentiation experiments. Briefly, neurospheres were dissociated into single 
cells and plated onto laminin-coated Lab-Tek 8-well permanox chamber slides 
(Nunc) at a density of 43,750 cells/cm
2
 in NPC differentiation medium (NDM, 
Neurobasal-A medium supplemented with B27, 2 mM L-glutamine and 100 
U/100 µg/ml Penicillin/Streptomycin). NPC were treated in presence of 
hippocampal astrocyte conditioned media (ACM) derived from WT or NF-κB 
p50KO glial cultures, or in presence of NDM (referred to as standard, STD 
medium) for 24 h. WT NPC were treated in presence of 0.01–1 µg/ml 
recombinant mouse lipocalin-2 (LCN-2, Cell Signaling), 2 µg/ml purified 
human Thrombospondin-1 (hTSP-1, Amsbio), or corresponding vehicle for 24 
h. For RAGE inhibition, 60 min before ACM or NDM treatment, 20 μg/ml 
neutralizing polyclonal anti-RAGE antibody (α-RAGE Ab; R&D System) was 
added to NPC. 
 
Primary Astrocyte Cultures. Primary mixed glial cultures were prepared from 
cortex and hippocampus of neonatal (P1-2) C57BL/6 WT and p50KO mice and 
grown in DMEM high glucose, 10% FBS, 15 mM HEPES, 2 mM L-glutamine 
and 100 U/100 µg/ml Penicillin/Streptomycin at a density of 78,000 cells/cm
2
. 
When cells reached confluence (around 10-12 D.I.V.), proliferation of non-
astrocytic cells was blocked by 10 µM cytosine arabinoside (Sigma-Aldrich) for 
96 h. Then cultures were switched to NDM. Phenotypic characterization of 
cultures was performed by immunocytochemistry with antibodies against GFAP 
(mouse monoclonal, 1:600, Millipore) and CD11b (rat monoclonal; 1:150, 
Millipore). Contaminating microglial cells were below 3% of total cells, with 
the remaining cells being GFAP
+
. ACM was collected after 48h in presence of 
NDM. Briefly, ACM was centrifuged for 10 min at 16,000 x g to eliminate cells 
and debris and passed through 0.2 μm filter before use. ACM was used diluted 





Immunolocalization studies in differentiated adult hippocampal NPC. NPC 
were treated in presence of WT or p50KO ACM or STD medium for 24 h. 
Phenotypic characterization of NPC-derived cells was carried out by 
immunolocalization for MAP-2 (rabbit polyclonal, 1:600; Millipore), GFAP 
(mouse monoclonal, 1:600; Millipore), nestin (chicken monoclonal, 1:1,500; 
Neuromics), NG-2 (rabbit  polyclonal, 1:500; Millipore). Secondary antibodies 
were as follows: Alexa Fluor 555-conjugated goat anti-rabbit (1:1,400; 
Molecular Probes); Alexa Fluor 488-conjugated goat anti-chicken antibody 
(1:1,400; Molecular Probes); Alexa Fluor 488-conjugated goat anti-rabbit 
(1:1,400; Molecular Probes), Alexa Fluor 488-conjugated goat anti-mouse 
(1:1,600; Molecular Probes). Nuclei were counterstained with 0.8 ng/ml 
Hoechst (Thermo Fisher scientific) diluted in PBS. In each experiment, 5 
fields/well (corresponding to about 150-200 cells/well) were counted with a 
60X objective by a Leica DMIRB inverted fluorescence microscope. Cells 
positive for each marker were counted and their percentage over total viable 
cells was calculated. All experiments were run in triplicates using different cell 
preparations and repeated at least three times. 
 
LC-MS/MS analysis and protein quantification. WT and p50KO ACM were 
subjected to trichloroacetic acid (TCA) precipitation. Briefly, TCA was added 
to a final 12% (wt/vol) concentration and kept on ice for 2 h, followed by 
centrifugation (16,000 x g, 10 min). The supernatant was carefully removed, 
and 1 ml of tetrahydrofuran (pre-cooled in ice) was added to each pellet and 
vortexing was carried out until the pellet dissolved completely. Proteins were 
then reduced with dithiothreitol (DTT), alkylated by iodoacetamide, and 
digested with trypsin at 37°C O/N. Data acquisition was performed with a 
micro-LC Eksigent Technologies (Dublin, USA) system, with a stationary 
phase a Halo Fused C18 column (0.5 x 100 mm, 2.7 µm; Eksigent 
Technologies), interfaced with a Triple-TOF 5600+ system (AB SCIEX) 
equipped with a DuoSpray Ion source. The mobile phase was a mixture of 0.1% 




eluting at a flow-rate of 15.0 mL min-1 at an increasing concentration of solvent 
B from 2% to 40 % in 30 minutes. An initial data-dependent acquisition (DDA) 
analysis was performed on the p50KO and WT ACM samples to generate the 
SWATH-MS (Sequential Window Acquisition of Theoretical mass spectra) 
spectral library: the mass spectrometer analysis was performed using a mass 
range of 100–1500 Da (TOF scan with an accumulation time of 0.25 s), 
followed by a MS/MS product ion scan from 200 to 1250 Da (accumulation 
time of 5.0 ms) with the abundance threshold set at 30 cps (35 candidate ions 
can be monitored during every cycle). The samples were then subjected to 
cyclic data independent analysis (DIA) of the mass spectra, using a 25-Da 
window: the mass spectrometer was operated such that a 50-ms survey scan 
(TOF-MS) was performed and subsequent MS/MS experiments were performed 
on all precursors. These MS/MS experiments were performed in a cyclic 
manner using an accumulation time of 40 ms per 25-Da swath (36 swaths total) 
for a total cycle time of 1.5408 s (Venable et al., 2004, Geromanos et al., 2009; 
Gillet et al., 2012). The ions were fragmented for each MS/MS experiment in 
the collision cell using the rolling collision energy. The MS data were acquired 
with Analyst TF 1.7 (AB SCIEX). Three replicates for each sample were 
subjected to the DIA analysis. The mass spectrometry files were searched using 
Protein Pilot (AB SCIEX) and Mascot (Matrix Science Inc.). For Protein Pilot 
the following parameters were used: cysteine alkylation, digestion by trypsin, 
no special factors and False Discovery Rate at 1%. For Mascot the following 
parameters were used: the digestion enzyme selected was trypsin, with 3 missed 
cleavages, a search tolerance of 0.4 Da was specified for the peptide mass 
tolerance, and 0.4 Da for the MS/MS tolerance. The charges of the peptides to 
search for, were set to 2+, 3+ and 4+, the search was set on monoisotopic mass 
and the following modifications were specified for the search: carbamidomethyl 
cysteins as fixed modification and oxidized methionine as variable 
modification. The search was conducted using the UniProt Swiss-Prot database 
of mouse proteins (version 25.03.2015, containing 41741 sequence entries). 




FDR test from target-decoy database search with a cutoff p-value of 0.05, and 
protein/peptide confidence above 95% probability, with a minimum of two 
unique peptides per protein.  
The label-free quantification was performed with Skyline (MacCoss Lab 
Software, University of Washington) by importing the SWATH-MS runs. The 
library of the identified proteins used for the processing of SWATH data was 
generated by combining the results of the database search performed with 
Protein Pilot and Mascot (Manfredi et al., 2016). The quantification was 
performed by integrating the extracted ion chromatogram of all the unique ions 
for a given peptide and by using MSstats, a Skyline external tool for statistical 
analysis as previously described (Choi et al., 2014).  
 
Western blot analysis. Protein extracts from adult NPC cultures were obtained 
by lysis in 3X vol/vol of ice-cold hypotonic RIPA buffer [50 mM Tris-HCl pH 
7.5, 150 mM NaCl, 0.5 mM EDTA pH 8, 1% (vol/vol) Triton X-100, 1% 
(wt/vol) SDS, 10 mM NaF, 1 mM NaVO4, 1 mM DTT, protease inhibitor mix 
(Sigma-Aldrich)] for 30 min on ice. To complete the lysis, incubation at -80°C 
for 3 min followed by 2 min at 37°C was repeated three times. All lysates were 
centrifuged at 16,100 x g for 10 min at 4°C and supernatants were collected. 
Protein concentration was determined by Bradford assay (Sigma-Aldrich) and 
equivalent protein amounts (25 μg) were separated by SDS-PAGE gel (6%) and 
transferred onto nitrocellulose membranes. The membranes were blocked with 
5% BSA in TBS (Sigma-Aldrich) buffer for 60 min at RT. Immunoblots were 
carried out overnight in an antibody solution containing 3% (wt/vol) BSA in 
TBS-tween 0.1% with the primary antibody against the α2δ subunit of 
Dihydropyridine (DHP)/Thrombospondin-1 receptor (1:500; Sigma-Aldrich). 
After washing, blots were incubated with peroxidase-conjugated goat anti-
mouse antibody (1:10,000; BIO-RAD) for 60 min at RT and immunocomplexes 
were visualized by the Supersignal West Pico Chemiluminescent substrate 




system (Bio-Rad Laboratories) and each band was normalized to β-actin signal 
(mouse monoclonal, 1:1,000; Sigma-Aldrich). 
 
Statistical analysis. All experiments were run in triplicates using different cell 
preparations and repeated at least three times. Data were expressed as mean ± 
S.D. and analyzed using Student’s t-test when only two independent groups 
were compared, or by one-way analysis of variance (ANOVA) followed by 
Tuckey’s post-hoc test when three or more groups were compared. Statistical 







In vitro WT and p50KO ahNPC do not show differences in neuronal 







 NPC isolated from adult mouse 
hippocampi can be maintained for several passages in an undifferentiated 
proliferative state (Cuccurazzu et al., 2013). When grown onto laminin-coated 
chamberslides, upon removal of growth factors and exposure to a serum-free 
defined medium (STD medium), NPC stop dividing and spontaneously 
differentiate toward the neuronal lineage. As previously published, by double 
immunolabeling for markers of neuronal cells (MAP-2) and undifferentiated 









 neuroblasts can be evaluated and quantified (Meneghini et 
al., 2013). Under these experimental conditions, both WT- and p50KO-derived 










 cells: 32.22 ± 3.16 and 33.15 ± 2.21 % for WT and p50KO 
NPC; Figure 1). No significant difference in the subpopulations of 




cells: 12.86 ± 2.29 and 





cells: 51.79 ± 3.83 and 51.23 ± 4.51 % for WT and p50KO 
NPC; Figure 1) was present. Interestingly, despite the role of the NF-κB 
signaling pathway in the regulation of cell fate, no significant difference in the 
basal apoptotic rate could also be observed between the two genotypes (11.84 ± 
6.52 and 12.40 ± 5.87 % for WT and KO NPC; Figure 1), in agreement with the 
in vivo observation in hippocampi of adult WT and p50KO mice (Denis-Donini 
et al., 2008). Altogether we concluded that, unlike in vivo conditions, absence 
of NF-κB p50 did not correlate with altered neuronal differentiation of ahNPC 









Figure 1. Adult hippocampal NPC derived from WT and p50KO mice show 
similar in vitro differentiation and apoptotic rates. Under differentiating conditions, 
WT and p50KO hippocampal NPC spontaneously give rise to four cell populations 





















 cells). WT and p50KO hippocampal NPC show 
similar differentiation rate toward neuronal lineage. The apoptotic rate is not 
significantly different in WT and p50KO NPC. Data are expressed as mean values ± 
S.D. of n = 4 experiments, run in triplicates, and analyzed by Student’s t-test.  
 
 
Effect of WT- and p50KO-derived ACM on neuronal differentiation of WT 
ahNPC cultures 
The dissonant consequences of NF-κB p50 absence between in vitro and in vivo 
data prompted us to investigate the possibility that non-cell autonomous effects 
were contributing to remarkably reduced hippocampal neurogenesis in p50KO 
mice (Denis-Donini et al, 2008). Soluble factors released by astrocytes have 
been shown to modulate differentiation of NPC (Song et al., 2002). Based on 




soluble factors on the differentiation rate of ahNPC toward neuronal and non-
neuronal lineages. Primary mixed glial cultures were prepared from cortex and 
hippocampus of neonatal (P1-2) WT and p50KO mice. When cells reached 
confluence, proliferation of non-astrocytic cells was blocked by 10 µM cytosine 
arabinoside so to obtain an astrocytic-enriched cell population with less than 
3% of contaminating microglia. Astrocyte-conditioned medium (ACM), diluted 
1:2, was added to WT ahNPC cultures. Under these experimental conditions, 
we tested the effect of WT and p50KO ACM, in comparison with standard 
differentiation (STD) medium, on NPC differentiation. After 24 h, a significant 
increase in the percentage of in vitro generated neurons and neuroblasts was 
observed in WT cells exposed to WT-derived ACM, compared to STD medium 




 cells in STD and WT 




 cells in STD 
and WT ACM, p < 0.001; Figure 2 A, B). Under the same in vitro experimental 
conditions, no significant difference was observed between STD medium and 




 cells in STD and 




 cells in STD 
and p50KO ACM; Figure 2 A, B), suggesting that, in absence of NF-κB p50, 
primary astrocytes could not produce proneurogenic molecule(s) or, 
alternatively, did produce antineurogenic molecule(s). To investigate whether 
ACM could affect cell survival in addition to neuronal differentiation, we also 
analyzed the apoptotic rate of ahNPC and their progeny. No difference in the 
percentage of apoptotic cells was observed in the different media conditions 
(16.37 ± 2.04, 14.92 ± 1.51, 14.56 ± 1.46 %, in presence of STD, WT and 
p50KO ACM, respectively; Figure 2 C). Altogether these data suggested that 
the absence of NF-κB p50 may affect the secretory profile of astrocytes, and in 
particular may reduce their proneurogenic potential on ahNPC, in absence of 










Figure 2. WT, but not p50KO ACM, promote neuronal differentiation of WT 
ahNPC cultures. A-B, Under differentiating conditions, 24h treatment of WT 










compared with standard differentiation medium (STD). Conversely, p50KO ACM was 
devoid of proneurogenic effect. (C) No significant difference was observed in the 
apoptotic rate of cultures exposed to STD medium, WT and p50KO ACM. D-F, 
Representative confocal microscopy images of MAP2
+
 cells (green) generated from 
ahNPC after 24h in presence of STD medium (D), WT ACM (E) and p50KO ACM (F). 
Nuclei were counterstained with Hoechst (blue). Magnification = 400X. Scale bar = 20 
μm. Data are expressed as mean values ± S.D. of n = 3 experiments, run in triplicates 
and analyzed by one-way ANOVA followed by Tukey’s post hoc test. 
***








Both WT- and p50KO-derived ACM significantly promote astroglial 
differentiation of WT ahNPC. 
When exposed to STD medium in absence of growth factors, ahNPC also 
spontaneously differentiate toward the astrocytic lineage and that commitment 
is already apparent within 24 h (Meneghini et al., 2013). Interestingly, we 
observed a significant increase in the percentage of GFAP
+ 
cells being 
generated in vitro when WT NPC were exposed to both WT and p50KO ACM 
compared to STD medium condition (GFAP
+ 
cells: 16.0  1.71, 36.98  6.36, 
44.63  6.70 % in presence of STD, WT and p50KO ACM, respectively; WT 
ACM vs vehicle, p < 0.001, p50KO ACM vs vehicle; p < 0.001; Figure 3 A, C-
E). These data confirm that primary astrocytes produce soluble factors that 
promote astrogliogenesis in vitro, as previously demonstrated (Barkho et al., 
2006). Moreover, they indicate that such soluble activities, unlike 
proneurogenic ones, are secreted even in absence of NF-κB p50. Actually, in 
our experimental setting p50KO ACM was more effective than WT ACM in 
promoting astrogliogenesis in ahNPC cultures (Student’s t-test, p < 0.05; Figure 
3 A). A subpopulation of NG-2
+
 cells is also present both in proliferating and 
differentiating conditions in our cellular model. NG-2
+
 cells, also known as 
polydendrocytes, are commonly regarded as oligodendrocyte precursor cells 
(Nishiyama et al., 2009) but also, although controversial, as multipotential 
progenitors (Kondo and Raff, 2000). Interestingly, under differentiating 
conditions, the percentage of NG-2
+
 cells was not different in presence of the 
different media conditions (NG-2
+ 
cells: 23.44  11.35, 23.50  11.83, 23.17  
9.87 % in STD, WT and p50KO ACM, respectively; Figure 3 B, F-H). 
Altogether these in vitro data suggest that the absence of p50 selectively 
disrupts the proneurogenic potential of ACM, while astrogliogenic-derived 
signals are intact and even enhanced. Furthermore, these results support the 
hypothesis that defective hippocampal neurogenesis in p50KO mice could, at 







Figure 3. Both WT and p50KO ACM promote astroglial differentiation of WT 
ahNPC. A, 24h treatment of WT ahNPC with WT and p50KO ACM significantly 
increased the percentage of GFAP
+
 astroglial cells, compared with STD medium. 
p50KO ACM was more effective on astrogliogenesis than WT ACM. B, No significant 
differences was observed in the percentage of NG-2
+ 
cells upon different media 
conditions. C-H, Representative confocal microscopy images of ahNPC cultures 
differentiated in presence of STD (C, F), WT ACM (D, G) and p50KO ACM (E, H), 
and immunolabelled for GFAP (C-E) and NG-2 (F-H). Nuclei were counterstained 
with Hoechst (blue). Magnification = 400X. Scale bar = 20 μm. Data are expressed as 
mean values ± S.D. of n = 3 experiments, run in triplicates and analyzed by one-way 
ANOVA followed by Tukey’s post hoc test. 
***
p < 0.001 versus STD; 
# 
p < 0.05 versus 




p50KO NPC are unresponsive to neuronal and astroglial differentiation signals 
from both WT- and p50KO astrocytes  
We then tested the effect of WT and p50KO ACM on p50KO NPC 
differentiation toward neuronal and non-neuronal lineages. Surprisingly, neither 
WT nor p50KO ACM promoted neuronal differentiation of p50KO NPC, and 
their effect was indistinguishable from that of STD medium (Figure 4 A-B). 




cells) were 3.04  
0.32, 3.05  0.43, 3.14  0.59 % in response to STD medium, WT and p50KO 





 cells) were 32.69  2.19, 31.06  3.54, 31.81  
2.34 % in presence of STD medium, WT and KO ACM, respectively (Fig. 4 B). 
In addition, unlike WT NPC, p50KO NPC did not even respond to the 
astrogliogenic effects of WT and p50KO ACM (GFAP
+
 cells: 14.25  2.57, 
16.87  3.64, 17.08  2.14 %, for STD medium, WT and p50KO ACM 
treatment, respectively; Figure 4 C). Similarly, to what observed in WT NPC, 
we could not observe any difference in the percentage of NG-2
+
 cells when 
p50KO NPC were exposed to different media conditions (NG-2
+ 
cells: 29.49  
5.13, 28.29  5.48, 27.38  6.82 %, in STD, WT and p50KO ACM, 
respectively, Figure 4 D). Finally, also in p50KO cultures apoptotic rates were 
not different in presence of the different media conditions (data not shown). 
Altogether these data suggested that, in absence of NF-κB p50, cell autonomous 
changes profoundly affect both neuronal and astroglial differentiation of ahNPC 











Figure 4. p50KO NPC are unresponsive to neuronal and astroglial differentiation 
signals from both WT- and p50KO astrocytes.  
A-B, Under differentiating conditions, 24h treatment of p50KO hippocampal NPC with 









 neuroblasts (B), compared to STD condition. C-D, No significant 
difference was observed in the percentage of GFAP
+ 
cells (C), and NG-2
+ 
cells (D) in 
presence of STD medium, WT and p50KO ACM. Data are expressed as mean values ± 
S.D. of n = 3 experiments, run in triplicates. Data were analyzed by one-way ANOVA 
followed by Tukey’s post hoc test.  
 
 
The Receptor for Advanced Glycated End-products (RAGE) is not involved in 
the proneurogenic activity of ACM on WT ahNPC differentiation. 
RAGE is functionally expressed by ahNPC (Meneghini et al., 2010) and its 
activation by astrocytes derived molecules, like HMGB-1 and S100B, results in 
the promotion of neuronal differentiation of ahNPC (Meneghini et al., 2013). In 
order to understand if the activation of RAGE could mediate the proneurogenic 




anti-RAGE antibody (α-RAGE Ab, 20 μg/ml). α-RAGE Ab was not able to 
counteract the increase of MAP-2
+
 cells induced by WT ACM (MAP-2
+ 
cells: 
3.56 ±0.31, 6.23 ± 0.71, 5.15 ± 0.62 %, for STD, WT ACM and WT ACM + α-
RAGE Ab respectively, p < 0.05; Figure 5 A). These data suggested that 
proneurogenic soluble factors in WT ACM do not exert their action through 
RAGE engagement on ahNPC.    
 
 
p50KO NPC are defective in their response to thrombospondin-1 and display 
downregulated α2δ1 expression  
Thrombospondin-1 (TSP-1) is an astrocyte-derived proneurogenic factor (Lu 
and Kipnis, 2010). Recently our group demonstrated that α2δ1, a 
thrombospondin-1 (TSP-1) receptor (Eroglu et al., 2009), is functionally 
expressed by ahNPC (Valente et al., 2012). We evaluated α2δ1 expression 
levels in WT and p50KO ahNPC by western blot analysis. Interestingly, the 
α2δ1 subunit appeared strongly downregulated in p50KO compared with WT 
NPC (-59.5%; p < 0.05, Figure 5 B, C). As expected, recombinant human TSP-
1 (2 µg/ml) promoted an increase in the percentage of newly formed neurons in 




cells: 5.90 ± 1.18 
and 3.45 ± 0.64 % in TSP-1 and vehicle-treated cells; p < 0.001 vs vehicle; 
Figure 5 D). Conversely, TSP-1 treatment was ineffective in p50KO NPC 
(Figure 5 D). Overall these data confirmed that, in absence of p50, cell 
autonomous defects may reduce ahNPC responsiveness to astrocyte-derived 








Figure 5. p50KO NPC are defective in their proneurogenic response to 
thrombospondin-1 and display downregulated expression of α2δ1. A, Pretreatment 
with the neutralizing anti-RAGE antibody (20 μg/ml) does not counteract the 
proneurogenic effects of WT ACM on WT ahNPC, as assessed by MAP2
+
 cell 
counting.  B, Representative immunoblot analysis of α2δ1 subunit and β-actin 
expression levels in extracts of undifferentiated WT and p50KO ahNPC. Three (1-3) 
different WT and p50KO cell preparations were collected at different passages and 
analyzed. C, Quantification of α2δ1 expression levels in WT and p50KO NPC, 
normalized by β-actin, demonstrated downregulation in p50KO cultures. D, Under 
differentiating conditions, 24 h treatment of WT NPC with human recombinant TSP-1 




 cells, compared to 
vehicle. No effect was observed in TSP-1-treated p50KO NPC. Data are expressed as 
mean values ± S.D. of n = 4 experiments, run in triplicates.
 ***









Proteomic analysis of soluble factors released by WT and p50KO ACM 
In order to identify proteins which are secreted by WT and p50KO astrocytes, 
we analyzed ACM samples using a proteomic approach based on a hybrid 
system that combines the triple quadrupole technology with a time of flight 
mass spectrometer platform (Andrews et al. 2011). The analysis was performed 
on peptides produced by tryptic digestion of ACM proteins. Each sample was 
injected separately into the HPLC columns in a data dependent acquisition 
mode in order to build the spectra library of proteins identified from the runs. 
The protein spectra were then subjected to SWATH (Sequential Window 
Acquisition of Theoretical mass spectra) analysis, that allows complete 
evaluation of fragmented ions from detectable peptides in biological samples. 
Through this approach we were able to identify and quantify, as listed in Table 
1, four proteins differentially expressed in WT and p50KO ACM, with p values 
below 0.05. Specifically, the following proteins appeared upregulated in p50KO 
compared to WT ACM: neutrophil gelatinase-associated lipocalin-2 
(NGAL/LCN-2), C-C motif chemochine-2 (CCL2), H-2 class I 
Histocompatibility antigen, K-K alpha chain (HA1K) and retinoic acid receptor 
responder 2 (RARRES2). The complete list of proteins identified in WT and 
p50KO ACM is enclosed as supplementary files. 
 
Table 1. Differentially expressed proteins in WT and p50KO ACM as 
identified by LC-MS/MS. Peptide number, protein coverage percentage and 








Lipocalin-2 is an astrocyte-derived proneurogenic factor whose activity is 
strongly reduced in p50KO NPC. 
Lipocalin-2 (LCN-2) is 24 kDa iron-related protein whose modulatory role for 
diverse cell phenotypes in the CNS has recently attracted interest (Jha et al., 
2015). Since no data are currently available on the role of LCN-2 on adult 
neurogenesis we focused our attention on this protein as a contributor to lack of 
proneurogenic effects elicited by p50KO ACM. We tested recombinant mouse 
LCN-2 (0.01-1 µg/ml) initially on differentiating WT ahNPC. LCN-2 
promoted, in a concentration-dependent manner, neuronal differentiation of WT 




 cells in 
presence of the recombinant protein or vehicle (One-way ANOVA; p < 0.001, 
Fig. 6 A). Maximal proneurogenic effect was elicited in presence of 0.1 µg/ml 
LCN-2 (% of increase over vehicle-treated cells: + 84.11 ± 7.96, p < 0.001; 
Figure 6 A). Under the same concentration range, LCN-2 had no effect on cell 
survival (Figure 6 B). When tested on p50KO NPC LCN-2 was ineffective up to 
0.3 µg/ml and only 1 µg/ml of the protein significantly increased the percentage 
of newly generated neurons (% of increase over vehicle-treated cells: + 67.83 ± 
15.73, p < 0.001; Figure 6 A). Altogether, these data suggest, for the first time, 
that the protein LCN-2 is an astroglial-derived signal which promotes neuronal 
fate specification of ahNPC and whose activity is strongly reduced in p50KO 






Figure 6. Lipocalin-2 is a proneurogenic signal whose activity is reduced in p50KO 
NPC. A, 24 h treatment with mouse LCN-2 (0.01-1 µg/ml) promoted neuronal 
differentiation of WT ahNPC in a concentration-dependent manner. Under the same 
experimental conditions, p50KO NPC responsiveness to LCN-2 is reduced by one order 
of magnitude. B, LCN-2 has no effect on the survival rate of WT and p50KO NPC and 
their progeny. C-F, Representative confocal microscopy images of WT (C, D) and 
p50KO (E, F) ahNPC differentiated in presence of vehicle (C, E) and 0.1 µg/ml of 
LCN-2 (D, F) and immunolabeled for MAP-2 (green). Nuclei were counterstained with 
Hoechst (blue). Magnification = 400X. Scale bar = 20 μm. Data are expressed % as 
mean values ± S.D. of n = 3 experiments, run in triplicates, and analyzed by one-way 
ANOVA, followed by Tukey’s post hoc test. 
*
 p <0.05, 
***
p <0.001 versus WT vehicle; 
### 
p <0.001 versus p50KO vehicle; 
§
 p < 0.05, 
§§
 p < 0.01, 
§§§








    Since the initial observation of NF-κB members being present in adult 
neurogenic areas, data on the involvement of these regulatory proteins in the 
regulation of adult neurogenesis have exponentially grown (Grilli and 
Meneghini, 2012; Bortolotto et al., 2014). A few years ago we proved that 
p50KO mice display a dramatic reduction in adult hippocampal neurogenesis 
and, in parallel, a selective defect in hippocampal-dependent short-term 
memory. A detailed phenotypic characterization of newly generated 
hippocampal cells in p50KO mice suggested that absence of the NF-κB p50 
subunit may trigger a rather selective defect in neuronal differentiation of 
ahNPC, in absence of alterations in survival and proliferation rates (Denis-
Donini et al., 2008). As a follow up to that previous work, herein we show that 
when cultured in vitro, ahNPC from WT and p50KO mice are not significantly 
different in their neurogenic potential. Additionally, despite the well-known 
role of the NF-κB signaling pathway in the regulation of cell fate, no significant 
difference in the basal apoptotic rate could also be observed between the two 
genotypes. Altogether we concluded that, unlike in vivo conditions, absence of 
NF-κB p50 did not correlate with altered neuronal differentiation of ahNPC 
cultured alone in vitro.  
    Since the well documented role of NF-κB in non-neuronal cells (Brambilla et 
al., 2009; Lian et al., 2015; de la Fuente et al., 2015), we decided to further 
dissect the role of NF-κB p50 in the cross-talk between ahNPC and astrocytes. 
Exposure of WT and p50KO hippocampal NPC to conditioned media from WT 
and p50KO astrocytes was utilized as a strategy to study the potential influence 
of astroglia-generated soluble factors on adult NPC fate specification and the 
cell autonoumous or non-cell autonomous role played by NF-κB p50 signaling 
in that context. Initially we tested the effects of WT and p50KO astrocyte-
conditioned media on WT ahNPC. As previously shown (Song et al., 2002), 
also in our hands WT ACM promoted neuronal differentiation of ahNPC. 




astrogliogenesis of ahNPC, again in line with published reports (Chang et al., 
2003; Barkho et al., 2006). Interestingly, when ahNPC were exposed to p50KO 
ACM we could not observe proneurogenic effects. Conversely, p50KO ACM-
derived astrogliogenic signals appeared intact and even enhanced, compared to 
WT ACM. Of note, no differences in the survival rate of NPC and/or their 
progeny could be observed after exposure to WT or p50KO ACM. Altogether 
these data suggested that the absence of NF-κB p50 could affect the secretory 
profile of astrocytes, and in particular reduce their proneurogenic potential on 
ahNPC. It could be hypothesized that, in absence of NF-κB p50, primary 
astrocytes could either be defective in the production of proneurogenic 
molecule(s) or, alternatively, they could produce antineurogenic molecule(s). 
Furthermore our data suggested that astrocyte-derived astrogliogenic potential 
was not affected by NF-κB p50 absence. Altogether these results supported the 
initial hypothesis that defective hippocampal neurogenesis in p50KO mice 
could, at least in part, be ascribed to NF-κB p50-dependent changes in the 
secretome of astrocytes. We then tested the effect of WT and p50KO ACM on 
p50KO NPC differentiation toward neuronal and non neuronal lineages. 
Surprisingly, neither WT nor p50KO ACM promoted neuronal and astroglial 
differentiation of p50KO NPC over basal conditions, suggesting that in absence 
of NF-κB p50 cell autonomous changes may also occur and affect 
responsiveness of ahNPC to astrocyte-derived proneurogenic and astrogliogenic 
signals.  
    In search for phenotypic changes in p50KO NPC which may explain their 
reduced responsiveness to astrocyte-proneurogenic signals we took into 
consideration the possibility that these cells may have lost membrane receptors 
for astrocyte-derived proneurogenic molecules. RAGE, the Receptor for 
Advanced Glycation End-products is expressed by adult NPC (Meneghini et al, 
2010) and in hippocampal progenitors it mediates the proneurogenic effects of 
several molecules like HMGB-1 and S100B which can be secreted by 
astrocytes (Meneghini et al, 2013). Additionally, RAGE is the product of an 




initially evaluated the contribution of RAGE engagement on the proneurogenic 
effects of WT ACM in WT ahNPC, by using a previously characterized 
neutralizing antibody (Meneghini et al., 2013). Receptor neutralization had no 
effect on WT ACM proneurogenic effects, suggesting that RAGE activation 
was not involved in ACM-mediated neuronal differentiation of ahNPC. 
Thrombospondin-1 (TSP-1) is an established astrocyte-derived proneurogenic 
factor (Lu and Kipnis 2010). A few years ago, our group demonstrated that 
α2δ1 a thrombospondin-1 (TSP-1) receptor (Eroglu et al., 2009), is functionally 
expressed by ahNPC (Valente et al., 2012). Interestingly, α2δ1 expression 
levels resulted dramatically reduced in p50KO ahNPC, compared to their WT 
counterpart. In line with this observation, recombinant human TSP-1 promoted 
an increase in the percentage of newly formed neurons in WT, but not in 
p50KO, NPC cultures. Overall these data confirmed that, in absence of p50, cell 
autonomous defects may reduce ahNPC responsiveness to astrocyte-derived 
proneurogenic signals, and in particular to TSP-1, via downregulation of its 
receptor.  
    We also actively searched for proteins which may be differentially secreted 
by astrocytes in absence of p50 and whose expression could correlate with the 
lack of proneurogenic effects of p50KO ACM. LC-MS/MS allowed us to 
identify several proteins in WT and p50KO ACM. More specifically, four 
molecules were differentially expressed in WT and p50KO ACM, namely C-C 
motif chemochine-2 (CCL-2), neutrophil gelatinase-associated lipocalin-2 
(NGAL/LCN-2), H-2 class I Histocompatibility antigen, K-K alpha chain 
(HA1K), and retinoic acid receptor responder 2 (RARRES2, also known as 
chemerin). Interestingly, absence of NF-κB p50 is commonly linked to 
inflammation both in periphery and in brain (Bernal et al., 2014; Rolova et al., 
2014) and CCL-2, NGAL/LCN-2 and RARRES2/chemerin all share an 
established role in inflammation. Indeed, CCL-2 and RARRES2/chemerin are 
proinflammatory chemokines, while LCN-2 is an acute phase-protein. 




genes and NF-B signaling activation lies downstream their receptor activation 
(Ueda et al., 1994; Bu et al., 2006; Kohda et al., 2014).  
    We decided to focus our attention on NGAL/lipocalin-2 (LCN-2). It is a 24 
kDa iron-related protein which belongs to a family of diverse secreted proteins 
(Flower, 2000) and whose modulatory role in the CNS has recently attracted 
interest (Jha et al., 2015), although its function is not completely understood 
(Ferreira et al., 2015). LCN-2 is secreted by brain astrocytes and regarded as an 
autocrine promoter of their classical proinflammatory activation (Bi et al., 2013; 
Jang et al., 2013). Since no information was available on the role of LCN-2 on 
adult neurogenesis, we decided to concentrate our attention on this protein, 
whose expression is increased in p50KO compared to WT ACM. To our 
surprise, LCN-2 promoted, in a concentration-dependent manner, neuronal 









 cells in presence of the recombinant protein 
or of vehicle. In contrast with previous observations that LCN-2 can promote 
apoptosis of neurons and astrocytes (Lee et al., 2012; Tong et al., 2013), in our 
cellular model and within the tested concentration range the protein had no 
negative effect on the survival of ahNPC and their progeny. Interestingly, under 
the same experimental conditions, LCN-2 had no or little effect on neuronal 
differentiation of p50KO NPC, except at the highest concentration. Altogether, 
these data suggest, for the first time, that LCN-2 is an astroglial-derived signal 
which promotes neuronal fate specification of ahNPC and that p50KO NPC are 
less responsive to this protein. This observation points also to the possibility 
that, like for the TSP-1 receptor α2δ1, downregulation of LCN-2 receptor(s) 
may also occur in ahNPC and explain their reduced sensitivity (one order of 
magnitude) to this protein. In such respect increased expression of LCN-2 in 
conditioned media from p50KO astrocytes may represent a compensatory event 
to reduced LCN-2 receptor expression or sensitivity. Alternatively, the absence 
of p50 may disrupt intracellular signaling downstream several membrane 
receptors, including LCN-2 receptors, an aspect which deserves further 




brain type organic cation transporter (BOCT or 24p3R or LCN2R) which is 
constitutively expressed at high levels in brain, including in the hippocampus, 
in neuronal cells and in the choroid plexus (Ip et al, 2011), but it also appears to 
be upregulated in astrocytes and microglia in EAE and peripheral nerve injury 
(Berard et al, 2012; Jha et al., 2013). Interestingly, NF-κB signaling activation 
has been shown to occur downstream of LCN-2/24p3R (Dizin et al., 2013). The 
second one is megalin, also known as low density lipoprotein receptor-related 
protein 2 (Lrp2), a multiligand endocytic receptor which is expressed by many 
cell types in the CNS. Lrp2 binds about 40 different ligands ranging from 
lipoprotein and protease inhibitor complex to growth factors and extracellular 
matrix proteins (Spuch et al., 2012). Increasing evidence has implicated Lrp2, 
in Aβ clearance in Alzheimer’s Disease (Alvira-Botero et al., 2010). Recently, 
Lrp2 has also been involved in regulating the behaviour of neural stem and 
progenitor cells during development and in adulthood, although not in the 
hippocampus (Auderset et al., 2016). A detailed evaluation of BOCT and Lrp2 
expression levels in WT and p50KO ahNPC is certainly needed to complete the 
picture.  
Of course we cannot disregard other differentially expressed proteins as 
contributors in the lack of response of ahNPC to astrocyte-derived signals. 
Contradictory data have been gathered on the contribution of CCL-2 to 
neurogenesis. In vitro studies showed that incubation of NPC with CCL-2 
increase neuronal differentiation as proven by an increase in the number of 
Tuj1-positive cells, in absence of effects on cell proliferation and survival (Liu 
et al, 2007). On the other hand an involvement of CCL-2 in the reduction of 
neurogenesis associated with cranial irradiation has also been suggested (Lee et 
al., 2013). Preliminary evidence suggest that exogenously added CCL-2 is also 
proneurogenic on WT ahNPC cultures (data not shown). As far as 
RARRES2/chemerin, limited information is available on the physiological role 
of this protein and its receptor (CMKLR1) in the CNS. Targeting 
CMKLR1:chemerin interaction has been proposed to be beneficial in 




are no data pointing to its involvement in neurogenesis, recently a novel role for 
chemerin and its CMKLR1 receptor in regulating adipogenesis and 
osteoblastogenesis of bone marrow-derived precursor cells has been proposed 
(Muruganandan et al, 2010). Interestingly, chemerin is also an inducer of CCL-
2 (Eisinger et al., 2011). 
H-2 class I Histocompatibility antigen, K-K alpha chain (HA1K) was also 
identified by LC-MS/MS in astrocyte-conditioned media and appeared 
upregulated in p50KO ACM. Of course at this stage we cannot exclude that its 
presence in media may represent an artefact, but since exosomes bearing MHC 
Class I molecules have been previously demonstrated in other cell types 
(Zitvogel et al., 1998) in the future we will also explore the possibility that 
extracellular microvesicles of astrocytic origin could contribute, with their 
cargo, to ACM composition.  
Last but not least, in our experimental setting p50KO NPC appeared also 
unresponsive to astrogliogenic astrocyte-derived signals and we could exclude 
astrogliogenic effects of LCN-2 treatment on ahNPC (data not shown). In the 
future we may also attempt identifying the nature of those astrocyte secreted 
signals that regulate astrogliogenesis.  
In summary, although we cannot underestimate the contribution of other 
niche cell types which were not investigated (microglia in primis), herein we 
propose that reduced hippocampal neurogenesis in p50KO mice in vivo could 
be ascribed to complex cell autonomous and to non-cell autonomous defects in 
the cross-talk between astrocytes and adult hippocampal neural progenitor cells. 
Moreover, we show for the first time that LCN-2 is an astroglial-derived signal 
which promotes neuronal fate specification of ahNPC. Finally, these data add 
further complexity to the growing body of data suggesting the relevance of NF-
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Table 2. List of WT ACM proteins identified by Mascot and Protein Pilot 
database search, filtered for protein/peptide confidence above 95%, with a 




Accession Protein names Mass 
(Da) 
42.2 CO3_MOUSE Complement C3 (HSE-MSF) [Cleaved into: Complement C3 beta chain; C3-beta-
c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating 
protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c 
alpha' chain fragment 1; Complement C3dg fragment; Complement C3g 
fragment; Complement C3d fragment; Complement C3f fragment; Complement 
C3c alpha' chain fragment 2] 
186,484 
29.7 CLUS_MOUSE Clusterin (Apolipoprotein J) (Apo-J) (Clustrin) (Sulfated glycoprotein 2) (SGP-2) 
[Cleaved into: Clusterin beta chain; Clusterin alpha chain] 
51,656 
25 NGAL_MOUSE Neutrophil gelatinase-associated lipocalin (NGAL) (Lipocalin-2) (SV-40-induced 
24P3 protein) (Siderocalin LCN2) (p25) 
22,875 
22.2 APOE_MOUSE Apolipoprotein E (Apo-E) 35,867 
22 CATA_MOUSE Catalase (EC 1.11.1.6) 59,795 
17.3 CH3L1_MOUSE Chitinase-3-like protein 1 (BRP39 protein) (Breast regression protein 39) 
(Cartilage glycoprotein 39) (CGP-39) (GP-39) 
43,893 
15.4 K1C10_MOUSE Keratin, type I cytoskeletal 10 (56 kDa cytokeratin) (Cytokeratin-10) (CK-10) 
(Keratin, type I cytoskeletal 59 kDa) (Keratin-10) (K10) 
57,770 
15.1 FIGL1_MOUSE Fidgetin-like protein 1 (EC 3.6.4.-) 74,850 
12.4 AL1A1_MOUSE Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.36) (ALDH-E1) 
(ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde 
dehydrogenase, cytosolic) 
54,468 
11.4 CYTC_MOUSE Cystatin-C (Cystatin-3) 15,531 
10.8 CCL2_MOUSE C-C motif chemokine 2 (Monocyte chemoattractant protein 1) (Monocyte 
chemotactic protein 1) (MCP-1) (Platelet-derived growth factor-inducible protein 
JE) (Small-inducible cytokine A2) 
16,326 
10.4 NT5D3_MOUSE 5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-) (GRP94-neighboring 
nucleotidase) 
63,170 
8.7 CERU_MOUSE Ceruloplasmin (EC 1.16.3.1) (Ferroxidase) 121,151 
8.2 CXL10_MOUSE C-X-C motif chemokine 10 (10 kDa interferon gamma-induced protein) (Gamma-
IP10) (IP-10) (C7) (Interferon-gamma induced protein CRG-2) (Small-inducible 
cytokine B10) 
10,789 
8.1 GRAG_MOUSE Granzyme G (EC 3.4.21.-) (CTL serine protease 1) (MCSP-1) 27,381 
7.3 PAFA_MOUSE Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-
alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-
alkylglycerophosphocholine esterase) (LDL-associated phospholipase A2) (LDL-
PLA (2)) (PAF 2-acylhydrolase) 
49,258 
6.7 K1C17_MOUSE Keratin, type I cytoskeletal 17 (Cytokeratin-17) (CK-17) (Keratin-17) (K17) 48,162 
6.6 SKIT1_MOUSE Selection and upkeep of intraepithelial T-cells protein 1 (Skint-1) 
(Immunoglobulin-like and transmembrane domain-containing protein expressed 
in skin and thymus protein 1) 
41,792 
6.5 MCF2L_MOUSE Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming 
sequence-like protein) 
129,113 
6.3 NAA50_MOUSE N-alpha-acetyltransferase 50 (EC 2.3.1.-) (N-acetyltransferase NAT13) (NatE 
catalytic subunit) 
19,414 
6.2 RUND1_MOUSE RUN domain-containing protein 1 67,865 
6.2 TRRAP_MOUSE Transformation/transcription domain-associated protein (Tra1 homolog) 291,557 
6.1 CBPE_MOUSE Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) 





5.8 LIFR_MOUSE Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (D-factor/LIF 
receptor) (CD antigen CD118) 
122,574 
5.5 SCEL_MOUSE Sciellin 72,972 
5.3 ARAP3_MOUSE Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 
3 (Centaurin-delta-3) (Cnt-d3) (Dual specificity Rho- and Arf-GTPase-activating 
protein 1) 
169,741 
5.2 LG3BP_MOUSE Galectin-3-binding protein (Cyp-C-associated protein) (CyCAP) (Lectin 
galactoside-binding soluble 3-binding protein) (Protein MAMA) 
64,491 
5.2 ESYT3_MOUSE Extended synaptotagmin-3 (E-Syt3) 100,068 
5 BRE1A_MOUSE E3 ubiquitin-protein ligase BRE1A (BRE1-A) (EC 6.3.2.-) (RING finger protein 
20) 
113,520 
4.6 SPRC_MOUSE SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted 
protein acidic and rich in cysteine) 
34,450 
4.6 K1C42_MOUSE Keratin, type I cytoskeletal 42 (Cytokeratin-42) (CK-42) (Keratin-17n) (Keratin-
42) (K42) (Type I keratin Ka22) 
50,133 
4.6 TDR12_MOUSE Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-
associated transcript 8 protein) (Tudor domain-containing protein 12) 
137,627 
4.5 K22E_MOUSE Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial 
keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2) 
70,923 
3.9 NAA20_MOUSE N-alpha-acetyltransferase 20 (EC 2.3.1.88) (Methionine N-acetyltransferase) (N-
acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit 
NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB 
complex subunit NAT5) (NatB catalytic subunit) 
20,368 
3.8 K2C5_MOUSE Keratin, type II cytoskeletal 5 (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II 
keratin Kb5) 
61,767 
3.4 WDR64_MOUSE WD repeat-containing protein 64 123,893 
3.3 NCAN_MOUSE Neurocan core protein (Chondroitin sulfate proteoglycan 3) 137,200 
3.2 RAD54_HUMAN DNA repair and recombination protein RAD54-like (EC 3.6.4.-) (RAD54 
homolog) (hHR54) (hRAD54) 
84,352 
3.1 LBP_MOUSE Lipopolysaccharide-binding protein (LBP) 53,055 
3 BAI2_MOUSE Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2) 169,863 
2.9 FNIP2_MOUSE Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced 
apoptosis 1 protein) 
122,520 
2.8 CWC25_MOUSE Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing 
protein 49) (Spliceosome-associated protein homolog CWC25) 
48,811 
2.7 FREM1_MOUSE FRAS1-related extracellular matrix protein 1 (Protein QBRICK) 244,544 
2.3 SYIM_MOUSE Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) 
(IleRS) 
112,804 
2.3 ABHD8_MOUSE Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) 
(Abhydrolase domain-containing protein 8) 
48,229 
2.3 K2C79_MOUSE Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-79) (K79) 
(Type-II keratin Kb38) 
57,552 
2.3 CATZ_MOUSE Cathepsin Z (EC 3.4.18.1) 33,996 
2 FRAS1_MOUSE Extracellular matrix protein FRAS1 442,369 
1.9 ACTBL_MOUSE Beta-actin-like protein 2 (Kappa-actin) 42,004 
1.9 PNCB_MOUSE Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21) (Nicotinate 
phosphoribosyltransferase domain-containing protein 1) 
58,265 
1.7 ZBT49_MOUSE Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509) 83,091 
1.6 PPARD_MOUSE Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone 
receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) 
(Peroxisome proliferator-activated receptor beta) (PPAR-beta) 
49,715 
1.5 5HT2B_MOUSE 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (NP75 
protein) (Serotonin receptor 2B) 
53,597 
1.5 TMPSD_MOUSE Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine 
protease) (Mosaic serine protease) 
59,806 
1.5 COBA2_MOUSE Collagen alpha-2(XI) chain 171,535 
1.2 NSD1_MOUSE Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific (EC 
2.1.1.43) (H3-K36-HMTase) (H4-K20-HMTase) (Nuclear receptor-binding SET 





1.2 MKKS_MOUSE McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin (Protein Bbs6 
homolog) 
61,924 
1.1 FAT2_MOUSE Protocadherin Fat 2 (FAT tumor suppressor homolog 2) 480,109 
0.9 SSH3_MOUSE Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like 
protein 3) (SSH-3L) (mSSH-3L) 
72,227 
0.8 TLR4_MOUSE Toll-like receptor 4 (CD antigen CD284) 95,519 
0.7 ATP9B_MOUSE Probable phospholipid-transporting ATPase IIB (EC 3.6.3.1) (ATPase class II 
type 9B) 
129,017 
0.6 RC3H2_MOUSE Roquin-2 (EC 6.3.2.-) (Membrane-associated nucleic acid-binding protein) 




Table 3. List of p50KO ACM proteins identified by Mascot and Protein Pilot 
database search, filtered for protein/peptide confidence above 95%, with a 




Accession  Protein names Mass 
(Da) 
48.2 APOE_MOUSE Apolipoprotein E (Apo-E) 35,867 
42.6 SAA3_MOUSE Serum amyloid A-3 protein 13,774 
36.4 CO3_MOUSE Complement C3 (HSE-MSF) [Cleaved into: Complement C3 beta chain; C3-beta-c 
(C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating 
protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c 
alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; 
Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' 
chain fragment 2] 
186,484 
31.5 NGAL_MOUSE Neutrophil gelatinase-associated lipocalin (NGAL) (Lipocalin-2) (SV-40-induced 
24P3 protein) (Siderocalin LCN2) (p25) 
22,875 
28.1 CLUS_MOUSE Clusterin (Apolipoprotein J) (Apo-J) (Clustrin) (Sulfated glycoprotein 2) (SGP-2) 
[Cleaved into: Clusterin beta chain; Clusterin alpha chain] 
51,656 
25.7 CYTC_MOUSE Cystatin-C (Cystatin-3) 15,531 
23.9 SPA3N_MOUSE Serine protease inhibitor A3N (Serpin A3N) 46,718 
22.3 CCL2_MOUSE C-C motif chemokine 2 (Monocyte chemoattractant protein 1) (Monocyte 
chemotactic protein 1) (MCP-1) (Platelet-derived growth factor-inducible protein 
JE) (Small-inducible cytokine A2) 
16,326 
19.7 CBPE_MOUSE Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) 
(Enkephalin convertase) (Prohormone-processing carboxypeptidase) 
53,256 
18.1 CERU_MOUSE Ceruloplasmin (EC 1.16.3.1) (Ferroxidase) 121,151 
17.3 RARR2_MOUSE Retinoic acid receptor responder protein 2 (Chemerin) 18,350 
15.9 SCG3_MOUSE Secretogranin-3 (Secretogranin III) (SgIII) 53,326 
15 CFAB_MOUSE Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: 
Complement factor B Ba fragment; Complement factor B Bb fragment] 
85,004 
12.4 CCL7_MOUSE C-C motif chemokine 7 (Intercrine/chemokine MARC) (Monocyte chemoattractant 
protein 3) (Monocyte chemotactic protein 3) (MCP-3) (Protein FIC) (Small-
inducible cytokine A7) 
10,999 




9.3 CATD_MOUSE Cathepsin D (EC 3.4.23.5) 44,954 
9.3 KIF5C_MOUSE Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2) 109,275 
8.8 TIMP1_MOUSE Metalloproteinase inhibitor 1 (Collagenase inhibitor 16C8 fibroblast) (Erythroid-
potentiating activity) (EPA) (TPA-S1) (TPA-induced protein) (Tissue inhibitor of 
metalloproteinases 1) (TIMP-1) 
22,628 
8.2 CXL10_MOUSE C-X-C motif chemokine 10 (10 kDa interferon gamma-induced protein) (Gamma-
IP10) (IP-10) (C7) (Interferon-gamma induced protein CRG-2) (Small-inducible 
cytokine B10) 
10,789 
7.9 NAA20_MOUSE N-alpha-acetyltransferase 20 (EC 2.3.1.88) (Methionine N-acetyltransferase) (N-
acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit 
NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB 
complex subunit NAT5) (NatB catalytic subunit) 
20,368 
7.7 K1C10_MOUSE Keratin, type I cytoskeletal 10 (56 kDa cytokeratin) (Cytokeratin-10) (CK-10) 
(Keratin, type I cytoskeletal 59 kDa) (Keratin-10) (K10) 
57,770 
7.7 CATB_MOUSE Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; 
Cathepsin B heavy chain] 
37,280 
7.6 CAND1_MOUSE Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-
dissociated protein 1) (p120 CAND1) 
136,332 
7.1 K1C42_MOUSE Keratin, type I cytoskeletal 42 (Cytokeratin-42) (CK-42) (Keratin-17n) (Keratin-42) 
(K42) (Type I keratin Ka22) 
50,133 
6.9 FSTL1_MOUSE Follistatin-related protein 1 (Follistatin-like protein 1) (TGF-beta-inducible protein 
TSC-36) 
34,554 
6.8 PAFA_MOUSE Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-
alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-
alkylglycerophosphocholine esterase) (LDL-associated phospholipase A2) (LDL-
PLA(2)) (PAF 2-acylhydrolase) 
49,258 
6.7 LBP_MOUSE Lipopolysaccharide-binding protein (LBP) 53,055 
6.3 SPRC_MOUSE SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted 
protein acidic and rich in cysteine) 
34,450 
5.9 CAB39_MOUSE Calcium-binding protein 39 (MO25alpha) (Protein Mo25) 39,843 
5.9 DDX27_MOUSE Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 
27) 
85,939 
5.6 CTRO_MOUSE Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, 
serine/threonine-protein kinase 21) 
235,389 
5.5 CATA_MOUSE Catalase (EC 1.11.1.6) 59,795 
5.5 CH3L1_MOUSE Chitinase-3-like protein 1 (BRP39 protein) (Breast regression protein 39) (Cartilage 
glycoprotein 39) (CGP-39) (GP-39) 
43,893 
5.4 MYH7_MOUSE Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-
slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) 
222,879 
5.1 PLTP_MOUSE Phospholipid transfer protein (Lipid transfer protein II) 54,453 
4.4 KRT35_MOUSE Keratin, type I cuticular Ha5 (Hair keratin, type I Ha5) (Keratin-35) (K35) 50,530 
4.2 ABCA1_MOUSE ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) 
(ABC-1) (ATP-binding cassette 1) 
253,912 
4.1 K2C79_MOUSE Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-79) (K79) 
(Type-II keratin Kb38) 
57,552 
4 ACTBL_MOUSE Beta-actin-like protein 2 (Kappa-actin) 42,004 
3.6 NCAN_MOUSE Neurocan core protein (Chondroitin sulfate proteoglycan 3) 137,200 




3.3 K22E_MOUSE Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial 
keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2) 
70,923 
3.2 PPARD_MOUSE Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone 
receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome 
proliferator-activated receptor beta) (PPAR-beta) 
49,715 
3.1 TMCC1_MOUSE Transmembrane and coiled-coil domains protein 1 71,642 
2.8 CWC25_MOUSE Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing 
protein 49) (Spliceosome-associated protein homolog CWC25) 
48,811 
2.7 MOT10_MOUSE Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) 
(Solute carrier family 16 member 10) (T-type amino acid transporter 1) 
55,320 
2.3 RC3H2_MOUSE Roquin-2 (EC 6.3.2.-) (Membrane-associated nucleic acid-binding protein) (RING 
finger and CCCH-type zinc finger domain-containing protein 2) 
131,295 
2.3 ABHD8_MOUSE Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) 
(Abhydrolase domain-containing protein 8) 
48,229 
2 K1C15_MOUSE Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15) 49,138 
1.9 PNCB_MOUSE Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21) (Nicotinate 
phosphoribosyltransferase domain-containing protein 1) 
58,265 
1.8 LIFR_MOUSE Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (D-factor/LIF receptor) 
(CD antigen CD118) 
122,574 
1.7 DDX46_MOUSE Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 
46) 
117,448 
1.5 TMPSD_MOUSE Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine 
protease) (Mosaic serine protease) 
59,806 
1.4 CO4A2_MOUSE Collagen alpha-2(IV) chain [Cleaved into: Canstatin] 167,325 
1.2 LG3BP_MOUSE Galectin-3-binding protein (Cyp-C-associated protein) (CyCAP) (Lectin 
galactoside-binding soluble 3-binding protein) (Protein MAMA) 
64,491 
1 AKAP4_MOUSE A-kinase anchor protein 4 (AKAP-4) (A-kinase anchor protein 82 kDa) (AKAP 82) 
(mAKAP82) (FSC1) (Major sperm fibrous sheath protein) (Protein kinase A-
anchoring protein 4) (PRKA4) (p82) 
93,796 















Table 4. Raw data file of peptides used in SWATH-MS analysis for the 
identification and quantitation of the 4 differentially expressed proteins listed in 
Table 1.  
 








_MOUSE GNEQIFR SWATH_WTrep3 2471 #N/D 2471 
sp|P04223|HA1K
_MOUSE GNEQIFR SWATH_WTrep2 2702 #N/D 2702 
sp|P04223|HA1K
_MOUSE GNEQIFR SWATH_WTrep1 2340 #N/D 2340 
sp|P04223|HA1K
_MOUSE GNEQIFR SWATH_KOrep_4 10868 #N/D 10868 
sp|P04223|HA1K
_MOUSE GNEQIFR SWATH_KOrep_2 10213 #N/D 10213 
sp|P04223|HA1K
_MOUSE GNEQIFR SWATH_KOrep_1 11466 #N/D 11466 
sp|P04223|HA1K
_MOUSE GNEQIFR SWATH_KOrep_3 9993 #N/D 9993 
sp|P10148|CCL2_
MOUSE EAVVFVTK SWATH_WTrep3 153687 128204 25483 
sp|P10148|CCL2_
MOUSE EAVVFVTK SWATH_WTrep2 164498 140179 24319 
sp|P10148|CCL2_
MOUSE EAVVFVTK SWATH_WTrep1 146597 122183 24414 
sp|P10148|CCL2_
MOUSE EAVVFVTK SWATH_KOrep_4 661337 554219 107119 
sp|P10148|CCL2_
MOUSE EAVVFVTK SWATH_KOrep_2 662528 562099 100429 
sp|P10148|CCL2_
MOUSE EAVVFVTK SWATH_KOrep_1 605459 508588 96871 
sp|P10148|CCL2_
MOUSE EAVVFVTK SWATH_KOrep_3 583708 492348 91360 
sp|P10148|CCL2_
MOUSE KEWVQTYIK SWATH_WTrep3 32001 31099 902 
sp|P10148|CCL2_
MOUSE KEWVQTYIK SWATH_WTrep2 20523 19090 1433 
sp|P10148|CCL2_
MOUSE KEWVQTYIK SWATH_WTrep1 38266 36820 1446 
sp|P10148|CCL2_
MOUSE KEWVQTYIK SWATH_KOrep_4 71301 68320 2981 
sp|P10148|CCL2_
MOUSE KEWVQTYIK SWATH_KOrep_2 85960 83370 2591 
sp|P10148|CCL2_
MOUSE KEWVQTYIK SWATH_KOrep_1 63109 59543 3566 
sp|P10148|CCL2_
MOUSE KEWVQTYIK SWATH_KOrep_3 94789 91994 2794 
sp|P10148|CCL2_
MOUSE EWVQTYIK SWATH_WTrep3 155424 128374 27050 
sp|P10148|CCL2_
MOUSE EWVQTYIK SWATH_WTrep2 160812 128365 32447 
sp|P10148|CCL2_
MOUSE EWVQTYIK SWATH_WTrep1 178413 146207 32206 
sp|P10148|CCL2_
MOUSE EWVQTYIK SWATH_KOrep_4 329334 282540 46794 
sp|P10148|CCL2_
MOUSE EWVQTYIK SWATH_KOrep_2 329952 279782 50170 
sp|P10148|CCL2_
MOUSE EWVQTYIK SWATH_KOrep_1 329134 281025 48109 





MOUSE EWVQTYIK SWATH_KOrep_3 332781 289702 43079 
sp|P10148|CCL2_
MOUSE SSAPLNVK SWATH_WTrep3 153153 144243 8909 
sp|P10148|CCL2_
MOUSE SSAPLNVK SWATH_WTrep2 160286 150394 9892 
sp|P10148|CCL2_
MOUSE SSAPLNVK SWATH_WTrep1 191953 182631 9322 
sp|P10148|CCL2_
MOUSE SSAPLNVK SWATH_KOrep_4 516756 476254 40502 
sp|P10148|CCL2_
MOUSE SSAPLNVK SWATH_KOrep_2 487764 448050 39714 
sp|P10148|CCL2_
MOUSE SSAPLNVK SWATH_KOrep_1 499476 461775 37701 
sp|P10148|CCL2_
MOUSE SSAPLNVK SWATH_KOrep_3 459034 422266 36768 
sp|P11672|NGAL
_MOUSE WYVVGLAGNAVQK SWATH_WTrep3 135741 120467 15273 
sp|P11672|NGAL
_MOUSE WYVVGLAGNAVQK SWATH_WTrep2 199234 183843 15391 
sp|P11672|NGAL
_MOUSE WYVVGLAGNAVQK SWATH_WTrep1 171925 155501 16423 
sp|P11672|NGAL
_MOUSE WYVVGLAGNAVQK SWATH_KOrep_4 398726 350009 48717 
sp|P11672|NGAL
_MOUSE WYVVGLAGNAVQK SWATH_KOrep_2 439424 392870 46555 
sp|P11672|NGAL
_MOUSE WYVVGLAGNAVQK SWATH_KOrep_1 421031 371489 49542 
sp|P11672|NGAL
_MOUSE WYVVGLAGNAVQK SWATH_KOrep_3 435008 391324 43684 
sp|P11672|NGAL
_MOUSE TFVPSSR SWATH_WTrep3 160713 124169 36544 
sp|P11672|NGAL
_MOUSE TFVPSSR SWATH_WTrep2 150379 117681 32698 
sp|P11672|NGAL
_MOUSE TFVPSSR SWATH_WTrep1 164657 128344 36312 
sp|P11672|NGAL
_MOUSE TFVPSSR SWATH_KOrep_4 414944 320077 94868 
sp|P11672|NGAL
_MOUSE TFVPSSR SWATH_KOrep_2 423173 326578 96596 
sp|P11672|NGAL
_MOUSE TFVPSSR SWATH_KOrep_1 414689 319453 95236 
sp|P11672|NGAL




























DYNQFAMVFFR SWATH_KOrep_3 223409 213629 9780 
sp|P11672|NGAL
_MOUSE ELSPELK SWATH_WTrep3 146315 128375 17940 
sp|P11672|NGAL
_MOUSE ELSPELK SWATH_WTrep2 181324 154967 26357 
sp|P11672|NGAL
_MOUSE ELSPELK SWATH_WTrep1 123902 109046 14856 
sp|P11672|NGAL





_MOUSE ELSPELK SWATH_KOrep_2 399837 352828 47008 
sp|P11672|NGAL
_MOUSE ELSPELK SWATH_KOrep_1 380892 328979 51913 
sp|P11672|NGAL
















































Modulatory events within the adult hippocampal neurogenic niche: novel 
insights into region-specific astrocyte-derived signaling cues and the role 
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Active adult neurogenesis is well documented to occur in the adult mammalian 
brain in two discrete areas, the subventricular zone (SVZ) of the later ventricles, 
and the subgranular zone (SGZ) of the dentate gyrus (Ming and Song, 2005; 
Bond et al., 2015; Nicola et al., 2015). Growing evidence suggest the presence 
of another neurogenic area in the hypothalamus, along the walls of the third 
ventricle (Kokoeva et al., 2005). The neurogenic areas called niches are 
composed of different cell types and non-cellular components, such as soluble 
cues (i.e. growth factors, cytokines, hormones) originated both locally and 
distantly. In the neurogenic niches neural stem/progenitor cells (NSPC) are 
housed and supported by the different cellular and molecular components, that 
balance their proliferation and differentiation rates (Lin and Iacovitti, 2015). 
Astrocytes represent one major contributor of the hippocampal neurogenic 
niche. Hippocampal-derived astrocytes were demonstrated to promote 
neurogenesis both via directly interacting with adult hippocampal NSPC and 
through secreted factors (Song et al., 2002). On the other hand, astrocytes 
isolated from non-neurogenic areas, such as those isolated from the adult spinal 
cord were proven ineffective in promoting neurogenesis, while were effective in 
promoting gliogenesis (Barkho et al., 2006). Overall these data suggested that 
the astrocytes in adult neurogenic regions contribute to generate an instructive 
environment for neuronal differentiation of adult NSPC.  
Our group reported that  the NF-κB family of transcription factors are expressed 
at considerable levels in areas of active neurogenesis in the postnatal and adult 
mouse brain (Denis-Donini et al., 2005). Previous publications from our lab 
also reported that mice lacking NF-B p50 subunit display a dramatic reduction 
in adult hippocampal neurogenesis associated with short-term memory defects 
(Denis-Donini et al., 2008). Interestingly, NPC derived from WT and p50KO 
hippocampi do not display any differences in neuronal differentiation and 
apoptotic rates in vitro. These data suggested that impaired hippocampal 




between niche cells. In previous work in our laboratory (Cvijetic et al., under 
submission) we investigated NPC-astroglia communication and, in particular, 
the effect of soluble factors released by astrocytes derived from mixed culture 
of cortex/hippocampi on cell fate specification of WT and p50KO adult 
hippocampal NPC (ahNPC). We demonstrated that WT ACM promote both 
neuronal and astroglial differentiation of WT NPC, whereas p50KO ACM can 
only promote astrogliogenesis. Additionally, when p50KO NPC were exposed 
to WT and p50KO ACM, they showed unresponsiveness to both treatment 
conditions. 
As a follow up of these experiments, in the first part of this study, we addressed 
the importance of region-specificity in the effect of ACM on ahNPC. More 
specifically, we compared the proneurogenic and progliogenic properties of 
hippocampal and hypothalamic ACM deriving from WT and p50KO astrocytes 
on adult hippocampal WT NPC fate specification.  
A second line of investigation was aimed at assessing the differentiation of WT 
hypothalamic NPC in response to hippocampal ACM deriving from WT and 






Materials and Methods 
 
Adult mouse hippocampal (Hp) and hypothalamic (Hyt) neural progenitor cell 
(NPC) cultures. Hippocampi and hypothalami from three adult (3-4 month-old) 
C57BL/6 male mice were dissected and cell suspension was prepared as 
previously described (Valente et al, 2012). Cells were maintained as floating 
neurospheres through subsequent passages (P1-P30).  
 
NPC differentiation experiments. Differentiation experiments were carried out 
as previously described (Valente et al., 2012). Briefly, neurospheres (passages 
5-30) were dissociated into single NPC and plated onto laminin-coated Lab-Tek 
8-well permanox chamber slides (Nunc) at a density of 43,750 cells/cm
2
 in NPC 
differentiation medium (NDM, Neurobasal-A medium supplemented with B27, 
2 mM L-glutamine and 100 U/100 µg/ml Penicillin/Streptomycin). NPC were 
treated in presence of astrocyte conditioned media (ACM) derived from WT or 
NF-κB p50KO glial cultures (referred to as hippocampal, Hp – or 
hypothalamic, Hyt - ACM), or in presence of NDM (referred to as standard, 
STD medium) for 24 h.  
 
Primary Astrocyte Cultures. Primary mixed glial cultures were prepared from 
hippocampus and hypothalamus of neonatal (P1-2) C57BL/6 mice and grown in 
DMEM high glucose, 10% FBS, 15 mM HEPES, 2 mM L-glutamine and 100 
U/100 µg/ml Penicillin/Streptomycin at a density of 78,000 cells/cm
2
. When 
cells reached confluence (around 10-12 D.I.V.), proliferation of non-astrocytic 
cells was blocked by 10 µM cytosine arabinoside (Sigma-Aldrich) for 96h. 
Then cultures were switched to NDM. Phenotypic characterization of cultures 
was performed by immunocytochemistry with antibodies against GFAP (mouse 
monoclonal, 1:600, Millipore) and CD11b (rat monoclonal; 1:150, Millipore). 








Preparation of astrocyte-conditioned media (ACM). To prepare astrocyte-
conditioned medium we used cells at confluence. ACM was collected after 48h 
of conditioning of enriched glial cultures in presence of Neurobasal-A medium 
with B27 supplement. Medium collected was centrifuged for 10 min x 16,100 x 
g at 4°C, to detach cells and large debris, and filtered using 0.20 μm filter before 
use in NPC differentiation studies. Collected conditioned medium was stored at 
-80°C. The ACM was used with 1:2 dilutions in all experiments. 
 
Immunolocalization studies in adult hippocampal and hypothalamic NPC. 
Phenotypic characterization of NPC-derived cells was carried out by 
immunolocalization for MAP-2 (rabbit polyclonal, 1:600; Millipore), GFAP 
(mouse monoclonal, 1:600, Millipore), nestin (chicken monoclonal, 1:1500, 
Neuromics), NG-2 (rabbit polyclonal, 1:500; Millipore). Nuclei were 
counterstained with 0.8 ng/ml Hoechst (Thermo Fisher scientific) diluted in 
PBS. In each experiment, 5 fields/well (corresponding to about 150-200 
cells/well) were counted with a 60X objective by a Leica DMIRB inverted 
fluorescence microscope. Cells positive for MAP-2, GFAP and NG-2 were 
counted and their percentage over total viable cells was calculated.  
 
Statistical analysis. All experiments were run in triplicate using different cell 
preparations and repeated at least three times. Data were analyzed using 
Student’s t-test when only two independent groups were compared, or by one-
way analysis of variance (ANOVA) followed by Tukey's post-hoc when 
comparing more than three groups. Results were expressed as mean ± S.D. 








Hippocampal but not hypothalamic ACM can promote neuronal differentiation 
of hippocampal NPC. 
Soluble factors released by astrocytes have been shown to modulate 
differentiation of adult neural progenitor cells (NPC) (Song et al., 2002). Based 
on these observations we evaluated the effect of astrocyte-generated soluble 
factors on the differentiation rate of adult hippocampal NPC toward neuronal 






 NPC isolated 
from adult mouse hippocampi can be maintained for several passages in an 
undifferentiated proliferative state (Cuccurazzu et al., 2013). Upon removal of 
growth factors from medium, NPC stop dividing and differentiate onto laminin-
coated dishes. By double immunolabeling for markers of neurons (MAP-2) and 









neuroblasts, can be evaluated and 
quantified. Under these experimental conditions we tested the effect of 
hippocampal (Hp) and hypothalamic (Hyt) astrocyte-conditioned medium 
(ACM) in comparison with standard differentiation medium (STD). After 24 h, 
a significant increase in the percentage of mature neurons and neuroblasts was 
observed in cells exposed to Hp ACM, but not to Hyt ACM, compared to 





3.49  0.40, 5.69  0.67, 3.46  0.33 % in presence of STD medium, Hp and 




cells: 32.10  4.08, 40.46  2.66, 33.49   2.69 %, in presence of STD medium, 
Hp and Hyt ACM, respectively; ANOVA, p < 0.001 vs STD; Fig. 1 B). Under 
the same experimental in vitro conditions adult hippocampal NPC can also 
differentiate toward the astrocytic lineage. Interestingly, both Hp and Hyt ACM 
resulted in an increased percentage of GFAP
+ 
cells when compared to standard 
medium (GFAP
+
 cells: 14.53  1.48, 29.18  6.74, 36.42  5.10 in presence of 




Fig. 1 C). Conversely, the NG-2
+
 population of oligodendroglial precursor cells 
was not affected by the treatment with Hp and Hyt ACM compared to STD 
medium (NG-2
+
 cells: 30.35  6.00; 29.15  6.04, 34.91  4.59 %, in presence 
of STD medium, Hp and Hyt ACM; Fig. 1 D). To investigate whether ACM 
could promote cell survival in addition to neuronal differentiation, we also 
analyzed NPC apoptotic rate. No difference in the percentage of apoptotic cells 
was reported in presence of the different media (mean %  S.D. over total cells: 
9.08  1.23, 7.13  1.43, 6.86  1.73 % in presence of STD medium, Hp and 
Hyt ACM, respectively; Fig. 1 E). Altogether these data suggest that a certain 
degree of region-specificity in the proneurogenic but not in the astrogliogenic 
signals provided by astrocytes on adult hippocampal NPC. Apparently, only 
hippocampal astrocytes but not hypothalamic astrocytes can secrete 
proneurogenic signals for ahNPC. Conversely, both hippocampal and 




Figure 1.   Hypothalamic ACM, unlike Hippocampal ACM, does not promotes 
hippocampal NPC neuronal differentiation. Both ACM promote 














compared with STD. Conversely, Hyt ACM was devoid of proneurogenic effect. C, 
Astroglial population of GFAP
+ 
cells increased upon both Hp and Hyt ACM 
treatment. D, No significant differences was observed in the percentage of NG-2
+ 
cells upon different media conditions. E, No significant difference was observed in 
the apoptotic rate of cultures exposed to STD medium, Hp and Hyt ACM. Data are 
expressed as mean values ± S.D. of n = 3 experiments, run in triplicates and analyzed 




Hypothalamic NPC do not respond to proneurogenic soluble signals coming 
from the neurogenic astrocytes of the hippocampal niche. 
Recently hypothalamus was identified as a novel adult proneurogenic niche 
where newly formed neurons might contribute to the homeostatic control of 
many physiological behaviors related to hypothalamic functions, including 
energy balance regulation (Pierce and Xu 2010; Whalley 2012). In our 
laboratory we have set up and characterized an in vitro model of adult 
hypothalamic (Hyt) NPC (Salem et al, unpublished observations).  
We then asked how adult Hyt NPC respond to astrocyte-secreted signals. In 
order to do so, we tested hypothalamic WT NPC differentiation rate toward 
neuronal and glial lineages upon treatment with astrocyte conditioned media 
derived from the hippocampal niche. When we tested the effect of Hp ACM on 
hypothalamic NPC, we did not observe any effect on neuronal differentiation 




 cells: 4.61  0.54, 4.48  





cells: 35.27  4.15, 35.88  3.73 %, in presence of STD 
medium and Hp ACM, respectively; Fig. 2 B). Under the same experimental 
conditions we observed a significant increase in newly generated astroglial cells 
upon ACM treatment (GFAP
+ 
cells: 29.11  6.03, 44.09  2.35 %, in presence 
of STD medium and Hp ACM, respectively; Fig. 2 C). Interestingly, a small, 
but significant increase in the percentage of NG-2
+ 




was observed upon Hp ACM treatment (NG-2
+ 
cells: 33.12  3.49, 37.19  2.47 
%, in presence of STD medium and Hp ACM, respectively; Student’s t-test vs 
STD, Fig. 2 D). No difference in the percentage of apoptotic cells was reported 
between STD medium and Hp ACM treatment (mean % ± S.D. over total cells: 
6.91  1.01, 6.03  1.32 %, STD medium and WT ACM, respectively; Fig. 2 
E). Altogether, these preliminary data suggest that soluble molecules from 
hippocampal astrocytes are not able to promote neuronal differentiation of Hyt 
NPC. On the contrary, similarly to what we observed on Hp NPC, hippocampal 
ACM can promote astrogliogenesis from Hyt NPC. Additionally, Hp ACM 
increase the NG-2
+
 cell population only from Hyt NPC and not from Hp NPC. 
NG-2
+
 cells are commonly considered oligodendrocyte precursors (Nishiyama 
et al., 2009). Interestingly, it has been proposed that, although controversial, 
hypothalamic NG-2
+ 
cells, distributed throughout the mediobasal hypothalamus, 
may represent a population able to give rise to new neurons (Robins et al., 
2013). Future studies will be needed for understanding the nature of this 
population in our cell culture model, for example by assessing, under long-term 














from Hypothalamic NPC. A-B Under differentiating conditions, 24 h treatment of 
hypothalamic NPC with hippocampal ACM did not affect the percentage of the 








neuroblasts (B) compared with standard differentiation medium (STD). C, 
Conversely, hippocampal ACM was able to promote astroglial differentiation. D, Hyt 
NPC showed a significant increase in the percentage of NG-2
+ 
cells upon treatment 
with hippocampal ACM. E, No significant difference was observed in the apoptotic 
rate of cultures exposed to STD medium or hippocampal ACM. Data are expressed 
as mean values ± S.D. of n = 3 experiments, run in triplicates and analyzed by 














Similar effects of p50KO Hp and Hyt ACM on WT hippocampal NPC. 
We then evaluated if NF-κB p50 absence has different consequences on the 
soluble signals released by hippocampal and hypothalamic astrocytes. In order 
to do so, primary astrocyte cultures were set up also from both regions of 
p50KO animals, ACM were collected and then tested in parallel on 
Hippocampal NPC. As previously shown (see Cvijetic et al. under submission) 
Hp p50KO ACM promotes astrogliogenesis (Fig. 3 B) but not neurogenesis 





 cells: 3.31  0.43, 3.51  0.82, 3.34  0.67 % in presence of 
STD medium, Hp and Hyt p50KO ACM, respectively (Fig. 3 A); GFAP
+
 cells: 
13.16  1.40, 36.00  3.24, 30.38  5.15 % in presence of STD medium, Hp and 
Hyt p50KO ACM, respectively (ANOVA, p < 0.001 vs STD; Fig. 3 B). When 
we checked for NG-2
+
 oligodendroglial precursor cells, we did not observe any 
significant effect on NG-2
+
 cells differentiation upon any treatment (NG-2
+
 
cells: 30.36  0.98, 27.21  5.21, 35.58  4.28 % in presence of STD medium, 
Hp and Hyt p50KO ACM, respectively; Fig. 3 C). No difference in the 
percentage of apoptotic cells was reported in presence of the different media 
(mean %  SD over total cells: 8.33  0.54, 6.92  1.18, 7.18  1.52 % in 
presence of STD medium, Hp and Hyt p50KO ACM, respectively; Fig. 3 D). 
This subset of data suggests that absence of p50 subunit may not affect the 
astrogliogenic potential of both hippocampal and hypothalamic astrocytes on 














Figure 3.   No significant differences in the effects of p50KO Hippocampal and 
Hypothalamic ACM on WT hippocampal NPC. A, Under differentiating conditions, 
24h treatment of WT hippocampal NPC with Hp or Hyt ACM deriving from p50KO 
astrocytes does not induce neuronal differentiation compared with standard 
differentiation medium (STD). B, Conversely, both media are able to increase astroglial 
population of GFAP
+ 
cells. C, No significant difference was observed in the percentage 
of NG-2
+ 
cells upon different media conditions. D, No significant difference was 
observed in the apoptotic rate of cultures exposed to STD medium, Hp and Hyt ACM 
p50KO. Data are expressed as mean values ± S.D. of n = 3 experiments, run in 
triplicates and analyzed by one-way ANOVA followed by Tukey’s post-hoc test. *** p 
< 0.001 versus STD medium. 
 
 
We extended our analysis by testing the effect of Hp p50KO ACM on WT 
hypothalamic NPC. Also in this experiment, we confirmed that hippocampal 
p50KO ACM (like WT hippocampal ACM on hypothalamic NPC) could not 
produce proneurogenic effects compared to STD condition. In detail the 





cells, 4.61  0.54, 3.99  0.57 % in presence of STD medium and Hp p50KO 




 cells: 35.27  4.15, 33.57  3.83 
% in presence of STD medium and Hp p50KO ACM, respectively (Fig. 4 B); 
GFAP
+
 cells: 29.12  6.03, 47.35  1.95 % in presence of STD medium and Hp 
p50KO ACM, respectively (Student’s t-test, *** p < 0.001 vs STD; Fig. 4 C). 









medium and Hp p50KO ACM, respectively; Fig. 4 D). No difference was also 
present in the apoptotic rate in presence of the different media conditions (mean 
%  SD over total cells: 7.54  1.20, 6.32  1.53 % in presence of STD medium 
and Hp p50KO ACM, respectively; Fig. 4 E). These very preliminary data 
suggest that the absence of p50 may affect astrocyte secretion of soluble 
molecules which may promote an increase in the NG-2
+
 population originating 
from Hyt NPC.  
  
 
Figure 4.   Hypothalamic WT NPC, in presence of Hippocampal ACM originating 
from p50KO astrocytes, differentiate only toward the astroglial lineage. A-B 
Under differentiating conditions, 24 h treatment of WT hypothalamic NPC with Hp 
ACM deriving from p50KO astrocytes does not induce neuronal differentiation 
compared with standard differentiation medium (STD). C, Conversely, Hp p50KO 
ACM is still able to increase astroglial population of GFAP
+ 
cells. D, No significant 
differences was observed in the percentage of NG-2
+ 
cells upon Hp p50KO ACM 
treatment. E, No significant difference was observed in the apoptotic rate of Hyt NPC 
cultures exposed to STD medium versus Hp p50KO ACM. Data are expressed as mean 
values ± S.D. of n = 3 experiments, run in triplicates and analyzed by Student’s t-test 
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Scientific background  
Adult neurogenesis is a plastic and dynamic process that persists throghout 
post-natal life in mammalian species, including humans. Active sites of adult 
neurogenesis are the subventricular zone (SVZ) of the lateral ventricles, and the 
subgranular zone (SGZ) of the dentate gyrus in the hippocampus (Ming and 
Song, 2005; Bond and Song, 2015). Growing evidence suggests the presence of 
another neurogenic area in the hypothalamus, along the walls of the third 
ventricle (Kokoeva et al., 2005). The process of adult neurogenesis is supported 
by a pool of neural stem/progenitor cells (NSPC), which reside in a permissive 
microenvironment called “neurogenic niche”, where the different cellular types 
and molecular components provide a supportive milieu that balance NSPC 
quiescence along with proliferation and differentiation and survival (Lin & 
Iacovitti, 2015).  
Astrocytes represent one major contributor within the hippocampal neurogenic 
niche. Astrocytes isolated from neurogenic and non-neurogenic brain areas have 
been reported to exhibit different effects on the neuronal differentiation of 
NSPC suggesting that functional heterogeneity of astrocytes may reflect the 
different brain region environment (Song et al. 2002; Barkho et al. 2006). 
In previous publications our lab proved that members of the NF-B family of 
transcription factors are important contributors of signaling pathways in the 
SGZ neurogenic niche (Denis-Donini et al., 2005). Within the NF-B family, 
the p50 subunit appears to act as a crucial regulator of adult hippocampal neural 
progenitor cells (ahNPC). Specifically focusing on NF-B p50 subunit, our 
group has demonstrated that NF-B is involved in mediating the proneurogenic 
and antidepressive-like effect of some clinically relevant drugs (i.e. α2δ ligands; 
acetyl-L-carnitine) (Cuccurazzu et al., 2013; Valente et al., 2012), in the 
proneurogenic effects of damage-associated signals (i.e. HMGB-1 and Aβ1-2) 
(Meneghini et al., 2013), and that the absence of p50 affects the in vitro 
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response to those drugs/signals. In vivo our group also proved that p50KO mice 
display a dramatically reduced adult hippocampal neurogenesis which is in 
association with hippocampal-dependent short-term memory defects (Denis-
Donini et al., 2008).  
 
Working hypothesis  
The major project for the PhD thesis developed from the observation that unlike 
in vivo, hippocampal NPC derived from WT and p50KO adult mice have 
similar rate of differentiation, proliferation and apoptosis in vitro. We 
hypothesized that deficient signaling within the niche and/or intrinsic defects of 
NPC, might contribute to the reduced neurogenesis observed in vivo in p50KO 
mice. In particular, we focused on astrocytes as one of the relevant components 
in niche signaling and well-studied modulators in neurogenesis. We decided to 
explore ahNPC-astrocyte cross-talk in vitro in order to further dissect the 
contribution of non-cell autonomous signaling and cell autonomous defects, 
played by NF-B p50, in fate specification.  
 
Principal findings of the thesis work 
Based on these observations, we exploited the advantages of using primary cell 
culture systems to investigate the contribution made by astrocyte conditioned 
media (ACM), under basal conditions, on adult NPC fate specification. The 
most relevant finding concerning WT NPC cultures, was that neuronal fate 
determination is mediated only by WT ACM treatment, whereas p50KO ACM 
has no proneurogenic activity. On the contrary, both WT and p50KO ACM 
display astrogliogenic activity. The effect we observe in our experimental 
conditions are merely differentiative since ACM had no influence on the 
survival of NPC and their progeny. Interestingly, when we exposed p50KO 
NPC to WT and p50KO ACM, we did not observe any difference in lineage 
specification compared to STD condition, suggesting that also cell autonomous 
defects may affect the responsivity to proneurogenic and astrogliogenic signals 
secreted from the astrocytes. Previously our group demonstrated that α2δ1, a 
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thrombospondin-1 (TSP-1) receptor (Eroglu et al., 2009), is functionally 
expressed by ahNPC (Valente et al., 2012). During this PhD thesis we proved 
that α2δ1/TSP-1 receptor expression is downregulated in p50KO NPC. When 
we tested thrombospondin-1, a well-known proneurogenic glycoprotein of the 
extracellular matrix released by astrocytes (Lu & Kipnis, 2010) we observed a 
defective response to the proneurogenic molecule only in p50KO NPC and not 
in WT NPC. Overall these data suggest that absence of p50 may also reduce 
ahNPC responsiveness to TSP-1, an astrocyte-derived signal.  
A step forward in this study was done by analyzing the secretory profile of WT 
and p50KO astroglial cultures. By analyzing WT and p50KO ACM, we wanted 
(i) to explore if there were proteins differentially modulated under the control of 
NF-κB p50, (ii) to identify, among the detected proteins, potential 
proneurogenic or antineurogenic molecules, to be further validated in our in 
vitro system. Through LC-MS/MS proteomic analysis of ACM, we identified 
four proteins that were upregulated in p50KO compared to WT ACM: 
neutrophil gelatinase-associated lipocalin-2 (NGAL/LCN-2), C-C motif 
chemochine-2 (CCL-2), H-2 class I Histocompatibility antigen, K-K alpha 
chain (HA1K) and retinoic acid receptor responder 2 (RARRES2, chemerin). 
As a starting point, we focused our attention on Lipocalin-2 (LCN-2). No 
information is currently available on its role on adult neurogenesis. LCN-2 is 
mainly known as an acute phase protein secreted from activated microglia, 
reactive astrocytes and neurons. In the CNS, LCN-2 has been suggested to play 
a modulatory action in cognitive functions (Ferreira et al., 2013), neuronal 
excitability and anxiety (Mucha et al., 2011) and depression in human beings 
(Naudé et al., 2013). However, its precise role in the pathophysiology of the 
CNS remains to be outlined. We discovered for the first time that LCN-2 is able 
to elicit neuronal differentiation of WT ahNPC in a concentration-dependent 
fashion. Conversely, LCN-2 protein was found less active on p50KO ahNPC. 
These results, suggest for the first time that LCN-2 is an astroglial-derived 
signal that may promote neuronal differentiation of ahNPC and the lack of p50 
results in a reduced response to its proneurogenic activity. 
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As describerd in the unpublished section of this thesis, we also collected some 
preliminary data on the cross-talk between ahNPC and ACM originating from 
the hypothalamic area. The hypothalamic region has been discovered recently 
as a new neurogenic site, where neurogenesis might be regulated by growth 
factors, diet and hormones, given the involvement of this region in homeostatic 
and physiological processes (Kokoeva et al., 2005; Lee et al., 2014). As a 
follow up of the experiments performed before, we compared the proneurogenic 
and progliogenic properties of hippocampal and hypothalamic ACM deriving 
from WT astrocytes on adult hippocampal WT NPC fate specification. 
Additionally we assessed the contribution in NPC cell fate determination of 
hippocampal and hypothalamic astrocytes cultures deriving from NF-B 
p50KO mice. 
Our finding reports that hippocampal but not hypothalamic ACM can promote 
neuronal differentiation of hippocampal NPC, confirming that astrocytes may 
provide region-specific signals for the neurogenic process. This subset of data 
suggested us also that the astrogliogenic signals are still retained in absence of 
p50 subunit and independently of the origin of the astrocytes. We further 
explored the lineage fate determination of adult hypothalamic WT NPC in basal 
conditions and in response to hippocampal WT and p50KO ACM. We found 
out that hypothalamic WT NPC do not respond to proneurogenic soluble signals 
coming from WT hippocampal astrocytes. Conversely, hypothalamic NPC in 
presence of both WT and p50KO hippocampal ACM only differentiate toward 
astroglial lineage. Furthermore, we observed for the first time a pro-
differentiative effect of WT hippocampal ACM on oligodendroglial NG-2 cell 
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Conclusions and future perspectives 
 
    This work supports the concept that non-cell autonomous defects in astrocyte 
signaling might be relevant for the neurogenic process in vitro and, presumably, 
in vivo. We suggest that the absence of NF-κB p50 subunit in astrocytes is a 
critical aspect that negatively influence the proneurogenic activity of cortico-
hippocampal and hippocampal ACM.  
    On the other hand we comfirm that NPC intrinsic defects might be at the 
basis of the deregulated neurogenesis observed in p50KO mice, since 
hippocampal NPC have downregulated α2δ1 expression levels. Additionally we 
can confirm the importance of NF-B p50 in the regulation of proteins secreted 
by astrocytes, including new proneurogenic molecules such as LCN-2. 
    We also confirm the concept of region-specific regulation of ahNPC by 
molecular cues arising from the same neurogenic region. The field of region-
specific proneurogenic potential deserves further investigation. Moreover, it 
would be interesting to assess the responsiveness of hypothalamic NPC to 
proneurogenic moleclules relevant in hippocampal NPC neuronal 
differentiation (i.e. TSP-1, LCN-2). 
    Since LCN-2 was identified as an astrocyte-derived factor that exerts 
proneurogenic activity in WT NPC and to a lesser extent in p50KO NPC, we 
would like to further explore lipocalin-2 receptor expression, BOCT1/24p3R 
and megalin, in hippocampal WT and p50KO NPC. 
    Potential future work could also be aimed at understanding the involvement 
in neuronal fate determination of ahNPC for other proteins identified in 
astrocyte secretome, for example CCL-2. There are many reports claiming both 
negative and positive modulatory effects of the chemokine CCL-2 in neuronal 
differentiation of ahNPC. On one hand increased systemic levels of CCL-2 
observed during aging have been associated with decreased neurogenesis and 
age-related cognitive impairment (Villeda et al., 2011), on the other hand other 
results indicate that CCL-2 can influence both the migration, survival and fate 
choice of SVZ-derived neural precursor cells (Gordon et al., 2012). Therefore, 
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it could be interesting to evaluate WT and p50KO NPC responsiveness to this 
chemokine. 
    Another potential field of future investigation is that of intercellular 
communication via extracellular vesicles (EV), such as exosomes and shedding 
microvesicles, which are involved in neuronal protection, neuronal 
development, as well as neurodegeneration (Kalani et al., 2014; Rajendran et al. 
2014). It could be of interest exploring the involvement of EV as a possible 
novel mechanism of glia-to-NPC transfer of molecules which may affect NPC 
fate determination. Interestingly, LCN-2 and TSP-1 have both been reported to 
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